Clicky

Friday, November 20, 2026
All public companies · Official EDGAR

RIGLRIGEL PHARMACEUTICALS INC

Nasdaq · CIK 0001034842
Filer categoryAccelerated filer
Entity typeoperating
SIC2834 Pharmaceutical Preparations
FY end1231
XBRL facts356

Identity from submissions API

NameRIGEL PHARMACEUTICALS INC
CIK0001034842
TickersRIGL
ExchangesNasdaq
Entity typeoperating
CategoryAccelerated filer
SIC2834 Pharmaceutical Preparations
EIN943248524
LEI—
Fiscal year end1231
State of incorporationDE DE
Phone650-624-1100
Website—
Investor website—
Owner org03 Life Sciences
Flags—
Description—
Insider transactions (issuer)1
Insider transactions (owner)0

Former names

  • RIGEL PHARMACEUTICALS INC (2000-10-03T04:00:00.000Z → 2026-11-16T05:00:00.000Z)
Business address
611 GATEWAY BOULEVARD, SUITE 900
SOUTH SAN FRANCISCO
CA
94080
CA
Mailing address
611 GATEWAY BOULEVARD, SUITE 900
SOUTH SAN FRANCISCO
CA
94080
CA

EDGAR has no company-logo API. Website field is shown when the filer provided one.

Financialist coverage

SEC filings

1468 filing rows loaded from submissions recent; extra archives: CIK0001034842-submissions-001.json (468 filings, 2000-02-04 to 2007-12-16).

FiledFormDocumentItemsAccessionFile no.FilmActSizeXBRLiXBRL
2026-11-16 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0000052388-26-000507 005-59985 261558815 34 14454
2026-11-16 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0001172661-26-005251 005-59985 261558075 34 10567
2026-11-13 SCHEDULE 13G xslSCHEDULE_13G_X02/primary_doc.xml 0000895421-26-000335 005-59985 261553878 34 11952
2026-11-10 SCHEDULE 13G xslSCHEDULE_13G_X02/primary_doc.xml 0000093751-26-000717 005-59985 261538335 34 7996
2026-11-05 8-K 8-K 2.02,9.01 0001034842-26-000062 000-29889 261527388 34 302876 1 1
2026-11-05 10-Q 10-Q 0001034842-26-000061 000-29889 261527178 34 8431445 1 1
2026-09-03 4 FORM 4 0000905148-26-004080 19752
2026-09-03 4 FORM 4 0000905148-26-004079 4754
2026-09-03 4 FORM 4 0000905148-26-004078 4769
2026-09-03 4 FORM 4 0000905148-26-004077 4707
2026-08-14 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0001172661-26-003612 005-59985 261277293 34 10565
2026-08-13 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0001213900-26-088747 005-59985 261270263 34 20049
2026-08-04 S-8 S-8 0001034842-26-000055 333-297962 261239492 33 289877 1 1
2026-08-04 8-K 8-K 2.02,9.01 0001034842-26-000053 000-29889 261238724 34 302651 1 1
2026-08-04 10-Q 10-Q 0001034842-26-000052 000-29889 261238587 34 13386768 1 1
2026-07-10 4 FORM 4 0000905148-26-003238 5258
2026-07-01 8-K 8-K 5.02 0001034842-26-000045 000-29889 261145243 34 138205 1 1
2026-06-24 4 FORM 4 0000905148-26-003076 5013
2026-06-22 4 FORM 4 0000905148-26-003039 6043
2026-06-22 4 FORM 4 0000905148-26-003040 9098
2026-06-22 4 FORM 4 0000905148-26-003038 6045
2026-06-22 4 FORM 4 0000905148-26-003037 6090
2026-06-22 4 FORM 4 0000905148-26-003036 6046
2026-06-22 144 xsl144X01/primary_doc.xml 0001959173-26-004799 000-29889 261106501 33 5095
2026-06-17 8-K 8-K 2.01 0001034842-26-000043 000-29889 261098342 34 138008 1 1
2026-06-03 4 FORM 4 0000905148-26-002811 12328
2026-06-03 4 FORM 4 0000905148-26-002810 4572
2026-06-03 4 FORM 4 0000905148-26-002809 4570
2026-06-03 4 FORM 4 0000905148-26-002808 4525
2026-06-03 4 FORM 4 0000905148-26-002807 4525
2026-05-28 4 FORM 4 0000905148-26-002724 4752
2026-05-26 144 xsl144X01/primary_doc.xml 0001959173-26-003962 000-29889 261016638 33 4450
2026-05-20 8-K 8-K 5.02,5.07 0001034842-26-000041 000-29889 261004077 34 168409 1 1
2026-05-19 4 FORM 4 0000905148-26-002535 4918
2026-05-19 4 FORM 4 0000905148-26-002534 4891
2026-05-19 4 FORM 4 0000905148-26-002533 5215
2026-05-19 4 FORM 4 0000905148-26-002532 4992
2026-05-19 4 FORM 4 0000905148-26-002531 4910
2026-05-19 4 FORM 4 0000905148-26-002530 4876
2026-05-19 4 FORM 4 0000905148-26-002529 4939
2026-05-15 SCHEDULE 13G xslSCHEDULE_13G_X02/primary_doc.xml 0001172661-26-002177 005-59985 26984320 34 10440
2026-05-12 8-K 8-K 1.01 0001034842-26-000038 000-29889 26969970 34 143028 1 1
2026-05-07 SCHEDULE 13G xslSCHEDULE_13G_X02/primary_doc.xml 0001213900-26-053404 005-59985 26954687 34 33795
2026-05-05 8-K 8-K 2.02,9.01 0001034842-26-000033 000-29889 26943098 34 261561 1 1
2026-05-05 10-Q 10-Q 0001034842-26-000032 000-29889 26942980 34 6984372 1 1
2026-04-21 8-K 8-K 1.02 0001034842-26-000027 000-29889 26879695 34 139672 1 1
2026-04-03 DEFA14A DEFA14A 0001034842-26-000024 000-29889 26838036 34 661608
2026-04-03 DEF 14A DEF 14A 0001034842-26-000023 000-29889 26838024 34 5575401 1 1
2026-03-27 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0000102909-26-002200 005-59985 26803248 34 7194
2026-03-03 8-K 8-K 2.02,9.01 0001034842-26-000016 000-29889 26714176 34 299354 1 1
2026-03-03 10-K 10-K 0001034842-26-000015 000-29889 26713966 34 11671152 1 1
2026-02-24 4 FORM 4 0000905148-26-001015 8245
2026-02-20 144 xsl144X01/primary_doc.xml 0001959173-26-001277 000-29889 26658530 33 4282
2026-02-19 4 FORM 4 0000905148-26-000956 4756
2026-02-19 4 FORM 4 0000905148-26-000955 4755
2026-02-19 4 FORM 4 0000905148-26-000953 4801
2026-02-19 4 FORM 4 0000905148-26-000954 4803
2026-02-19 4 FORM 4 0000905148-26-000952 4759
2026-02-12 4 FORM 4 0000905148-26-000678 4391
2026-02-12 4 FORM 4 0000905148-26-000676 4388
2026-02-12 4 FORM 4 0000905148-26-000679 4435
2026-02-12 4 FORM 4 0000905148-26-000675 4387
2026-02-12 4 FORM 4 0000905148-26-000677 4433
2026-02-09 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0000093751-26-000084 005-59985 26609663 34 7921
2026-02-04 4 xslF345X05/form4.xml 0000905148-26-000498 4458
2026-02-04 4 xslF345X05/form4.xml 0000905148-26-000497 4412
2026-02-04 4 xslF345X05/form4.xml 0000905148-26-000496 4411
2026-02-04 4 xslF345X05/form4.xml 0000905148-26-000495 14640
2026-02-03 4 xslF345X05/form4.xml 0000905148-26-000482 5533
2026-02-03 3 xslF345X02/form3.xml 0000905148-26-000475 10485
2026-02-03 8-K 8-K 5.02 0001034842-26-000007 000-29889 26592678 34 140946 1 1
2026-01-12 8-K 8-K 2.02,8.01,9.01 0001034842-26-000005 000-29889 26524780 34 211605 1 1
2025-12-29 4 xslF345X05/form4.xml 0000905148-25-004492 14996
2025-12-10 8-K FORM 8-K 8.01,9.01 0001104659-25-119976 000-29889 251562010 34 221946 1 1
2025-11-14 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001172661-25-005151 005-59985 251488645 34 10758
2025-11-04 8-K FORM 8-K 2.02,9.01 0001104659-25-106282 000-29889 251449149 34 306824 1 1
2025-11-04 10-Q 10-Q 0001104659-25-106268 000-29889 251448967 34 10037321 1 1
2025-10-07 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0000895421-25-000532 005-59985 251380027 34 12305
2025-09-17 4 xslF345X05/form4.xml 0000905148-25-003351 5758
2025-09-17 4 xslF345X05/form4.xml 0000905148-25-003350 5802
2025-09-17 4 xslF345X05/form4.xml 0000905148-25-003349 5800
2025-09-17 4 xslF345X05/form4.xml 0000905148-25-003348 5755
2025-09-17 4 xslF345X05/form4.xml 0000905148-25-003347 5800
2025-08-14 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001172661-25-003610 005-59985 251222201 34 10691
2025-08-06 S-8 FORM S-8 0001104659-25-074440 333-289281 251187241 33 221329 1 1
2025-08-05 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001213900-25-072157 005-59985 251185947 34 19783
2025-08-05 10-Q 10-Q 0001558370-25-010281 000-29889 251184909 34 10072981 1 1
2025-08-05 8-K FORM 8-K 2.02,9.01 0001104659-25-074163 000-29889 251184809 34 298463 1 1
2025-05-28 4 xslF345X05/form4.xml 0000905148-25-001936 7051
2025-05-28 4 xslF345X05/form4.xml 0000905148-25-001935 7071
2025-05-28 4 xslF345X05/form4.xml 0000905148-25-001934 7024
2025-05-28 4 xslF345X05/form4.xml 0000905148-25-001933 7125
2025-05-28 4 xslF345X05/form4.xml 0000905148-25-001932 7043
2025-05-28 4 xslF345X05/form4.xml 0000905148-25-001931 6824
2025-05-23 8-K FORM 8-K 5.02,5.07 0001104659-25-052407 000-29889 25981985 34 206686 1 1
2025-05-15 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001172661-25-002295 005-59985 25952096 34 10687
2025-05-06 8-K FORM 8-K 2.02,9.01 0001104659-25-045067 000-29889 25917619 34 275984 1 1
2025-05-06 10-Q 10-Q 0001558370-25-006493 000-29889 25917207 34 8691711 1 1
2025-04-17 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001576419-25-000796 005-59985 25844742 34 10882
2025-04-10 ARS ARS 0001140361-25-013254 000-29889 25828505 34 12400647
2025-04-10 DEFA14A DEFA14A 0001140361-25-013251 000-29889 25828402 34 3815803
2025-04-10 DEF 14A DEF 14A 0001140361-25-013250 000-29889 25828379 34 11572786 1 1
2025-03-27 8-K FORM 8-K 8.01,9.01 0001104659-25-028564 000-29889 25775657 34 216890 1 1
2025-03-19 4 xslF345X05/form4.xml 0000905148-25-000980 8684
2025-03-19 4 xslF345X05/form4.xml 0000905148-25-000979 8728
2025-03-19 4 xslF345X05/form4.xml 0000905148-25-000978 5951
2025-03-19 4 xslF345X05/form4.xml 0000905148-25-000977 8730
2025-03-19 4 xslF345X05/form4.xml 0000905148-25-000976 8677
2025-03-10 4 xslF345X05/form4.xml 0000905148-25-000899 5197
2025-03-10 3 xslF345X02/form3.xml 0000905148-25-000898 8435
2025-03-10 8-K FORM 8-K 5.02 0001104659-25-022224 000-29889 25724932 34 199074 1 1
2025-03-04 8-K FORM 8-K 2.02,9.01 0001104659-25-020313 000-29889 25704570 34 314611 1 1
2025-03-04 10-K 10-K 0001558370-25-002169 000-29889 25704240 34 14254553 1 1
2025-02-14 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001172661-25-001264 005-59985 25630982 34 10711
2025-02-11 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001213900-25-012192 005-59985 25609662 34 21097
2025-02-07 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0000914208-25-000056 005-59985 25600809 34 7699
2025-02-06 4 xslF345X05/form4.xml 0000905148-25-000413 6008
2025-02-06 4 xslF345X05/form4.xml 0000905148-25-000412 6052
2025-02-06 4 xslF345X05/form4.xml 0000905148-25-000411 6048
2025-02-06 4 xslF345X05/form4.xml 0000905148-25-000410 6005
2025-02-05 144 xsl144X01/primary_doc.xml 0001959173-25-000721 000-29889 25593104 33 5130
2025-02-05 144 xsl144X01/primary_doc.xml 0001959173-25-000720 000-29889 25593010 33 5072
2025-02-05 144 xsl144X01/primary_doc.xml 0001959173-25-000719 000-29889 25592995 33 5107
2025-02-05 144 xsl144X01/primary_doc.xml 0001959173-25-000718 000-29889 25592991 33 5158
2025-02-05 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0002012383-25-001323 005-59985 25592325 34 11827
2025-02-04 144 xsl144X01/primary_doc.xml 0001959173-25-000699 000-29889 25588946 33 4439
2025-02-04 144 xsl144X01/primary_doc.xml 0001959173-25-000696 000-29889 25588724 33 4515
2025-02-04 144 xsl144X01/primary_doc.xml 0001959173-25-000688 000-29889 25588547 33 4461
2025-02-04 144 xsl144X01/primary_doc.xml 0001959173-25-000686 000-29889 25588540 33 4489
2025-01-31 4 xslF345X05/form4.xml 0000905148-25-000302 7002
2025-01-31 4 xslF345X05/form4.xml 0000905148-25-000301 6999
2025-01-31 4 xslF345X05/form4.xml 0000905148-25-000300 7289
2025-01-31 4 xslF345X05/form4.xml 0000905148-25-000299 7333
2025-01-31 4 xslF345X05/form4.xml 0000905148-25-000298 7289
2025-01-28 4 xslF345X05/form4.xml 0000905148-25-000237 13330
2025-01-24 144 xsl144X01/primary_doc.xml 0001959173-25-000469 000-29889 25554670 33 4329
2025-01-13 8-K FORM 8-K 2.02,8.01,9.01 0001104659-25-002874 000-29889 25524934 34 265542 1 1
2024-12-09 8-K FORM 8-K 8.01,9.01 0001104659-24-126758 000-29889 241535285 34 224862 1 1
2024-11-26 4 xslF345X05/form4.xml 0000905148-24-003283 5962
2024-11-26 4 xslF345X05/form4.xml 0000905148-24-003282 5960
2024-11-26 4 xslF345X05/form4.xml 0000905148-24-003281 5918
2024-11-14 SC 13G/A armistice-rigl093024a2.htm 0001172661-24-005331 005-59985 241464342 34 90758
2024-11-14 SC 13G/A AMENDMENT NO. 2 TO SCHEDULE 13G 0001213900-24-098330 005-59985 241461055 34 136149
2024-11-08 SC 13G SEC SCHEDULE 13G 0000914208-24-000503 005-59985 241438264 34 23957
2024-11-07 8-K FORM 8-K 2.02,9.01 0001104659-24-115334 000-29889 241436193 34 310905 1 1
2024-11-07 10-Q 10-Q 0001558370-24-014862 000-29889 241435580 34 10745006 1 1
2024-09-19 8-K FORM 8-K 5.02 0001104659-24-101327 000-29889 241310411 34 195074 1 1
2024-09-04 4 xslF345X05/form4.xml 0000905148-24-002512 5956
2024-09-04 4 xslF345X05/form4.xml 0000905148-24-002511 5918
2024-09-03 8-K FORM 8-K 1.01 0001104659-24-096047 000-29889 241272116 34 206841 1 1
2024-08-09 EFFECT xslEFFECTX01/primary_doc.xml S-3,,2024-08-09 16:30:00 9999999995-24-002483 333-281230 241194598 33 1767
2024-08-08 CORRESP filename1.htm 0001104659-24-087378 9245
2024-08-07 UPLOAD filename1.pdf 0000000000-24-009025 333-281230 40165
2024-08-06 S-8 S-8 0001104659-24-086334 333-281306 241180291 33 88314
2024-08-06 8-K FORM 8-K 2.02,9.01 0001104659-24-086271 000-29889 241179335 34 313865 1 1
2024-08-06 10-Q 10-Q 0001558370-24-011079 000-29889 241179126 34 9393670 1 1
2024-08-02 S-3 S-3 0001104659-24-085422 333-281230 241171832 33 979320
2024-06-27 8-K FORM 8-K 3.03,5.03,9.01 0001104659-24-075697 000-29889 241079730 34 215207 1 1
2024-06-25 8-K FORM 8-K 8.01,9.01 0001104659-24-074574 000-29889 241066268 34 233351 1 1
2024-05-29 4 xslF345X05/form4.xml 0000905148-24-001656 6884
2024-05-29 4 xslF345X05/form4.xml 0000905148-24-001655 6857
2024-05-29 4 xslF345X05/form4.xml 0000905148-24-001654 6958
2024-05-29 4 xslF345X05/form4.xml 0000905148-24-001653 6902
2024-05-29 4 xslF345X05/form4.xml 0000905148-24-001652 6875
2024-05-29 4 xslF345X05/form4.xml 0000905148-24-001651 6904
2024-05-29 8-K FORM 8-K 5.02,5.07 0001104659-24-066058 000-29889 24998359 34 215850 1 1
2024-05-07 8-K FORM 8-K 2.02,9.01 0001104659-24-058017 000-29889 24922126 34 337707 1 1
2024-05-07 10-Q 10-Q 0001558370-24-007041 000-29889 24921777 34 9257632 1 1
2024-04-12 8-K FORM 8-K 1.01 0001104659-24-046527 000-29889 24840031 34 200504 1 1
2024-04-10 ARS ARS 0001140361-24-019150 000-29889 24836718 34 2949378
2024-04-10 DEFA14A FORM DEFA14A 0001140361-24-019134 000-29889 24836405 34 1034117
2024-04-10 DEF 14A DEF 14A 0001140361-24-019133 000-29889 24836396 34 11314799 1 1
2024-03-29 PRE 14A PRE 14A 0001140361-24-016625 000-29889 24804697 34 11225580 1 1
2024-03-29 4 xslF345X05/form4.xml 0000905148-24-001016 5316
2024-03-29 3 xslF345X02/form3.xml 0000905148-24-001015 9349
2024-03-05 8-K FORM 8-K 2.02,9.01 0001104659-24-031010 000-29889 24720436 34 435049 1 1
2024-03-05 10-K 10-K 0001558370-24-002475 000-29889 24720288 34 12498399 1 1
2024-03-01 4 xslF345X05/form4.xml 0000905148-24-000851 8307
2024-03-01 4 xslF345X05/form4.xml 0000905148-24-000850 8351
2024-03-01 4 xslF345X05/form4.xml 0000905148-24-000849 8353
2024-03-01 4 xslF345X05/form4.xml 0000905148-24-000848 8311
2024-02-22 8-K FORM 8-K 1.01,2.01 0001104659-24-026338 000-29889 24662363 34 204934 1 1
2024-02-14 SC 13G/A armistice-rigl123123a1.htm 0001172661-24-001234 005-59985 24636146 34 90734
2024-02-13 SC 13G/A SCHEDULE 13G/A 0001104659-24-021843 005-59985 24629417 34 13090
2024-02-09 SC 13G MS INITIAL 0000895421-24-000137 005-59985 24613464 34 17579
2024-02-06 4 xslF345X05/form4.xml 0000905148-24-000447 6050
2024-02-06 4 xslF345X05/form4.xml 0000905148-24-000446 6456
2024-02-06 4 xslF345X05/form4.xml 0000905148-24-000445 6497
2024-02-05 SC 13G/A RIGEL.txt 0000769993-24-000044 005-59985 24597043 34 23745
2024-02-02 SC 13G/A AMENDMENT NO. 1 TO SCHEDULE 13G 0001213900-24-009383 005-59985 24589089 34 109797
2024-01-25 4 xslF345X05/form4.xml 0000905148-24-000309 7112
2024-01-25 4 xslF345X05/form4.xml 0000905148-24-000308 7151
2024-01-25 4 xslF345X05/form4.xml 0000905148-24-000307 7157
2024-01-25 4 xslF345X05/form4.xml 0000905148-24-000306 7113
2024-01-25 SC 13G/A us7665596034_012524.txt 0001086364-24-003211 005-59985 24561009 34 13376
2024-01-08 8-K FORM 8-K 2.02,8.01,9.01 0001104659-24-002085 000-29889 24518486 34 275729 1 1
2023-11-30 8-K FORM 8-K 3.01 0001104659-23-122171 000-29889 231453890 34 198283 1 1
2023-11-07 8-K FORM 8-K 2.02,9.01 0001104659-23-115245 000-29889 231384143 34 341887 1 1
2023-11-07 10-Q 10-Q 0001558370-23-017987 000-29889 231383658 34 8902150 1 1
2023-08-01 S-8 FORM S-8 0001104659-23-086398 333-273575 231132212 33 98413
2023-08-01 8-K FORM 8-K 2.02,9.01 0001104659-23-086368 000-29889 231131880 34 321248 1 1
2023-08-01 10-Q 10-Q 0001558370-23-012722 000-29889 231131660 34 8882602 1 1
2023-07-12 4 xslF345X04/form4.xml 0001140361-23-034286 12753
2023-07-12 4 xslF345X04/form4.xml 0001140361-23-034285 12343
2023-07-12 4 xslF345X04/form4.xml 0001140361-23-034288 12066
2023-07-12 4 xslF345X04/form4.xml 0001140361-23-034287 12752
2023-07-12 4 xslF345X04/form4.xml 0001140361-23-034284 12450
2023-07-12 4 xslF345X04/form4.xml 0001140361-23-034283 12357
2023-07-12 4 xslF345X04/form4.xml 0001140361-23-034282 12648
2023-06-12 SC 13G/A filing.txt 0000315066-23-002312 005-59985 231007172 34 8137
2023-05-30 8-K FORM 8-K 5.02,5.07 0001104659-23-065988 000-29889 23976204 34 212940 1 1
2023-05-15 DEFR14A DEFR 14A 0001140361-23-024734 000-29889 23923357 34 132816
2023-05-02 8-K FORM 8-K 2.02,9.01 0001104659-23-055028 000-29889 23879223 34 312744 1 1
2023-05-02 10-Q 10-Q 0001558370-23-007653 000-29889 23878899 34 7296163 1 1
2023-04-14 ARS ARS 0001140361-23-018395 000-29889 23819789 34 2830712
2023-04-14 DEFA14A FORM DEFA14A 0001140361-23-018394 000-29889 23819786 34 949281
2023-04-14 DEF 14A DEF 14A 0001140361-23-018393 000-29889 23819784 34 11365187 1 1
2023-03-07 S-8 FORM S-8 0001104659-23-029576 333-270329 23712928 33 75019
2023-03-07 8-K FORM 8-K 2.02,9.01 0001104659-23-029558 000-29889 23712782 34 343988 1 1
2023-03-07 10-K 10-K 0001558370-23-003035 000-29889 23712606 34 12315474 1 1
2023-02-22 SC 13G SC 13G 0001193125-23-044791 005-59985 23653012 34 105275
2023-02-14 SC 13G RIGEL.txt 0000769993-23-000281 005-59985 23627359 34 23421
2023-02-14 SC 13G armistice-rigl123122.htm 0001172661-23-001159 005-59985 23626315 34 90571
2023-02-09 SC 13G/A filing.txt 0000315066-23-002025 005-59985 23604998 34 7938
2023-02-09 SC 13G/A SCHEDULE 13G/A 0001104659-23-016854 005-59985 23604124 34 12952
2023-02-07 4 xslF345X03/form4.xml 0001140361-23-005036 8679
2023-02-06 4 xslF345X03/form4.xml 0001140361-23-004733 4483
2023-02-06 4 xslF345X03/form4.xml 0001140361-23-004732 4439
2023-02-06 4 xslF345X03/form4.xml 0001140361-23-004731 4564
2023-02-06 SC 13G Rigel_Pharmaceuticals_Inc.txt 0000093751-23-000237 005-59985 23589623 34 8318
2023-02-03 8-K FORM 8-K 5.02 0001104659-23-010536 000-29889 23586482 34 201488 1 1
2023-02-03 SC 13G/A us7665596034_020323.txt 0001306550-23-007789 005-59985 23586327 34 13149
2023-01-30 4 xslF345X03/form4.xml 0001140361-23-003443 5480
2023-01-30 4 xslF345X03/form4.xml 0001140361-23-003442 5546
2023-01-30 4 xslF345X03/form4.xml 0001140361-23-003441 9712
2023-01-30 4 xslF345X03/form4.xml 0001140361-23-003439 9756
2023-01-09 8-K FORM 8-K 2.02,8.01,9.01 0001104659-23-002074 000-29889 23516701 34 317230 1 1
2022-12-30 4 xslF345X03/form4.xml 0001140361-22-047667 12530
2022-12-30 4 xslF345X03/form4.xml 0001140361-22-047671 11322
2022-12-30 4 xslF345X03/form4.xml 0001140361-22-047669 11503
2022-12-30 4 xslF345X03/form4.xml 0001140361-22-047668 12480
2022-12-16 3 xslF345X02/form3.xml 0001140361-22-045884 9853
2022-12-02 8-K FORM 8-K 8.01,9.01 0001104659-22-123853 000-29889 221440197 34 236198 1 1
2022-11-29 8-K FORM 8-K 3.01 0001104659-22-122864 000-29889 221432817 34 196275 1 1
2022-11-03 10-Q 10-Q 0001558370-22-016266 000-29889 221358440 34 11660396 1 1
2022-11-03 8-K FORM 8-K 1.01,2.02,5.03,9.01 0001104659-22-114413 000-29889 221357901 34 626263 1 1
2022-11-01 8-K FORM 8-K 8.01,9.01 0001104659-22-113463 000-29889 221350207 34 226679 1 1
2022-10-11 8-K FORM 8-K 2.05,5.02,8.01,9.01 0001104659-22-107725 000-29889 221304233 34 221126 1 1
2022-10-11 SC 13G/A Rigel_Pharmaceuticals_Inc.txt 0000093751-22-000610 005-59985 221303607 34 8348
2022-10-11 SC 13G/A filing.txt 0000315066-22-001777 005-59985 221302558 34 7953
2022-09-22 SC 13G RIGL_SC13G_Sept22.htm 0001273087-22-000109 005-59985 221259248 34 81983
2022-09-16 4 FORM 4 0001140361-22-033613 5385
2022-09-16 4 FORM 4 0001140361-22-033612 5558
2022-09-16 4 FORM 4 0001140361-22-033611 5516
2022-08-03 S-8 FORM S-8 0001104659-22-085710 333-266501 221133682 33 101844
2022-08-02 8-K FORM 8-K 1.01,2.02,2.03,9.01 0001104659-22-085188 000-29889 221128819 34 344589 1 1
2022-08-02 10-Q 10-Q 0001558370-22-011638 000-29889 221128716 34 9064195 1 1
2022-07-25 8-K FORM 8-K 8.01 0001104659-22-082470 000-29889 221104256 34 194319 1 1
2022-07-11 SC 13G/A RIGEL_PHARMACEUTICALS_INC.txt 0000093751-22-000566 005-59985 221076303 34 10237
2022-06-23 8-K FORM 8-K 8.01 0001104659-22-073906 000-29889 221035681 34 196341 1 1
2022-06-13 4 FORM 4 0001567619-22-012778 4871
2022-06-08 8-K FORM 8-K 8.01,9.01 0001104659-22-069317 000-29889 221003690 34 265532 1 1
2022-05-23 4 FORM 4 0001140361-22-020308 6699
2022-05-23 4 FORM 4 0001140361-22-020307 6721
2022-05-23 4 FORM 4 0001140361-22-020306 6791
2022-05-23 4 FORM 4 0001140361-22-020305 6776
2022-05-23 4 FORM 4 0001140361-22-020304 6703
2022-05-23 4 FORM 4 0001140361-22-020303 6738
2022-05-23 4 FORM 4 0001140361-22-020302 6739
2022-05-23 8-K FORM 8-K 5.02,5.07 0001104659-22-063899 000-29889 22952466 34 205087 1 1
2022-05-03 EFFECT xslEFFECTX01/primary_doc.xml POS AM,0001104659-22-028718,2022-05-03 9999999995-22-001279 333-258426 22889639 33 1680
2022-05-03 8-K FORM 8-K 2.02,9.01 0001104659-22-055272 000-29889 22887072 34 281144 1 1
2022-05-03 10-Q 10-Q 0001558370-22-006809 000-29889 22886889 34 7667931 1 1
2022-04-05 DEFA14A FORM DEFA14A 0001140361-22-013179 000-29889 22807595 34 906636
2022-04-05 DEF 14A DEF 14A 0001140361-22-013177 000-29889 22807511 34 5295136
2022-03-01 S-8 FORM S-8 0001104659-22-028804 333-263187 22699947 33 84560
2022-03-01 POS AM POS AM 0001104659-22-028718 333-258426 22698808 33 587320
2022-03-01 8-K FORM 8-K 2.02,9.01 0001104659-22-028673 000-29889 22698072 34 302053 1 1
2022-03-01 10-K 10-K 0001558370-22-002551 000-29889 22697946 34 12201777 1 1
2022-03-01 POSASR POSASR 0001104659-22-028294 333-258426 22693714 33 584870
2022-02-17 8-K FORM 8-K 1.01,2.03 0001104659-22-024757 000-29889 22648582 34 197841 1 1
2022-02-14 SC 13G/A RIGEL_PHARMACEUTICALS_INC.txt 0000093751-22-000338 005-59985 22623926 34 8406
2022-02-10 SC 13G/A SCHEDULE 13G/A 0001104659-22-018464 005-59985 22610716 34 12945
2022-02-09 SC 13G/A filing.txt 0000315066-22-001294 005-59985 22604786 34 8805
2022-02-01 SC 13G/A us7665596034_020122.txt 0000834237-22-004471 005-59985 22579911 34 13357
2022-01-28 8-K FORM 8-K 5.02,9.01 0001104659-22-008984 000-29889 22568790 34 201318 1 1
2022-01-26 4 FORM 4 0001567619-22-001782 7264
2022-01-26 4 FORM 4 0001567619-22-001781 7238
2022-01-26 4 FORM 4 0001567619-22-001780 7308
2022-01-26 4 FORM 4 0001567619-22-001779 7262
2022-01-26 4 FORM 4 0001567619-22-001778 7129
2022-01-10 8-K FORM 8-K 2.02,8.01,9.01 0001104659-22-002534 000-29889 22519866 34 258744 1 1
2021-12-17 8-K FORM 8-K 5.02 0001104659-21-151192 000-29889 211502171 34 196588 1 1
2021-12-17 4 FORM 4 0001567619-21-022261 5539
2021-12-17 3 FORM 3 0001567619-21-022259 9377
2021-11-15 8-K FORM 8-K 2.05 0001104659-21-138665 000-29889 211406704 34 197976 1 1
2021-11-05 4 FORM 4 0001567619-21-019430 5766
2021-11-05 4 FORM 4 0001567619-21-019429 5630
2021-11-05 4 FORM 4 0001567619-21-019428 5766
2021-11-05 4 FORM 4 0001567619-21-019427 5907
2021-11-02 8-K FORM 8-K 2.02,9.01 0001104659-21-132987 000-29889 211371191 34 299064 1 1
2021-11-02 10-Q 10-Q 0001558370-21-014076 000-29889 211371113 34 9481056 1 1
2021-09-10 SC 13G/A SEC SCHEDULE 13G 0000902219-21-000392 005-59985 211245957 34 32877
2021-08-13 8-K FORM 8-K 8.01,9.01 0001104659-21-105111 000-29889 211172346 34 232785 1 1
2021-08-03 S-3ASR S-3ASR 0001104659-21-099567 333-258426 211141152 33 1276531
2021-08-03 8-K FORM 8-K 2.02,9.01 0001104659-21-099471 000-29889 211140228 34 301477 1 1
2021-08-03 10-Q 10-Q 0001558370-21-009976 000-29889 211139656 34 9107752 1 1
2021-06-21 S-8 FORM S-8 0001104659-21-083460 333-257226 211030418 33 86096
2021-05-21 4 FORM 4 - 0001179110-21-005772 6952
2021-05-21 4 FORM 4 - 0001179110-21-005771 6966
2021-05-21 4 FORM 4 - 0001179110-21-005770 6953
2021-05-21 4 FORM 4 - 0001179110-21-005769 6976
2021-05-21 4 FORM 4 - 0001179110-21-005768 6993
2021-05-21 4 FORM 4 - 0001179110-21-005767 6983
2021-05-21 4 FORM 4 - 0001179110-21-005766 7045
2021-05-21 4 FORM 4 - 0001179110-21-005765 7029
2021-05-21 8-K FORM 8-K 5.02,5.07 0001104659-21-070459 000-29889 21948900 34 215032 1 1
2021-05-18 4 FORM 4 - 0001179110-21-005550 5447
2021-05-18 3 FORM 3 - 0001179110-21-005548 6330
2021-05-14 8-K FORM 8-K 5.02 0001104659-21-066458 000-29889 21922132 34 195879 1 1
2021-05-05 10-Q 10-Q 0001558370-21-005903 000-29889 21893129 34 8764640 1 1
2021-05-05 8-K FORM 8-K 2.02,9.01 0001104659-21-061696 000-29889 21893096 34 297747 1 1
2021-04-13 8-K FORM 8-K 8.01,9.01 0001104659-21-049830 000-29889 21823793 34 243729 1 1
2021-04-06 DEF 14A DEF 14A 0001104659-21-047180 000-29889 21810055 34 5704987
2021-04-02 4 FORM 4 - 0001179110-21-004128 5575
2021-04-02 4 FORM 4 - 0001179110-21-004127 5704
2021-04-02 4 FORM 4 - 0001179110-21-004126 5706
2021-03-02 10-K 10-K 0001558370-21-002254 000-29889 21703514 34 12017875 1 1
2021-03-02 8-K 8-K 2.02,9.01 0001104659-21-030711 000-29889 21703414 34 313923 1 1
2021-02-18 8-K FORM 8-K 1.01 0001104659-21-025010 000-29889 21647608 34 203765 1 1
2021-02-16 SC 13G/A RIGL_SC13GA2.htm 0001319244-21-000137 005-59985 21639699 34 128406
2021-02-11 SC 13G RIGEL_PHARMACEUTICALS_INC.txt 0000093751-21-000243 005-59985 21616682 34 8400
2021-02-10 SC 13G/A SCHEDULE 13G/A 0001104659-21-018994 005-59985 21611876 34 13814
2021-02-08 SC 13G/A filing.txt 0000315066-21-001205 005-59985 21599788 34 8736
2021-02-04 SC 13G/A SEC SCHEDULE 13G 0000902219-21-000300 005-59985 21589849 34 37314
2021-02-03 8-K FORM 8-K 5.02,9.01 0001104659-21-011506 000-29889 21586158 34 202201 1 1
2021-01-29 4 FORM 4 - 0001179110-21-000986 8157
2021-01-29 4 FORM 4 - 0001179110-21-000985 5348
2021-01-29 4 FORM 4 - 0001179110-21-000984 5302
2021-01-29 4 FORM 4 - 0001179110-21-000983 5173
2021-01-29 4 FORM 4 - 0001179110-21-000982 5300
2021-01-27 SC 13G/A us7665596034_012621.txt 0000834237-21-002134 005-59985 21556033 34 13259
2021-01-11 8-K FORM 8-K 2.02,9.01 0001104659-21-002993 000-29889 21521189 34 261947 1 1
2020-11-05 10-Q 10-Q 0001558370-20-012838 000-29889 201290392 34 8372596 1 1
2020-11-05 8-K FORM 8-K 2.02,9.01 0001104659-20-121776 000-29889 201290308 34 314752 1 1
2020-10-08 8-K FORM 8-K 5.02 0001104659-20-113467 000-29889 201231472 34 192870 1 1
2020-08-20 4 FORM 4 - 0001179110-20-009207 5291
2020-08-20 3 FORM 3 - 0001179110-20-009204 6387
2020-08-04 S-8 S-8 0001104659-20-090388 333-240371 201074333 33 109062
2020-08-04 424B5 424B5 0001047469-20-004389 333-223564 201074291 33 330713
2020-08-04 10-Q 10-Q 0001558370-20-009154 000-29889 201073696 34 9103641 1 1
2020-08-04 8-K FORM 8-K 2.02,9.01 0001104659-20-090262 000-29889 201073257 34 318793 1 1
2020-07-10 SC 13G/A us7665596034_071020.txt 0000834237-20-009960 005-59985 201022211 34 13253
2020-05-15 4 FORM 4 - 0001179110-20-006136 5412
2020-05-15 4 FORM 4 - 0001179110-20-006135 5214
2020-05-15 4 FORM 4 - 0001179110-20-006134 5221
2020-05-15 4 FORM 4 - 0001179110-20-006133 5231
2020-05-15 4 FORM 4 - 0001179110-20-006132 5283
2020-05-15 4 FORM 4 - 0001179110-20-006131 5203
2020-05-15 4 FORM 4 - 0001179110-20-006130 5191
2020-05-15 4 FORM 4 - 0001179110-20-006129 5267
2020-05-15 8-K 8-K 5.02,5.07 0001104659-20-062621 000-29889 20885403 34 48158
2020-05-05 8-K FORM 8-K 2.02,9.01 0001104659-20-056879 000-29889 20849036 34 92257
2020-05-05 10-Q 10-Q 0001558370-20-005179 000-29889 20848837 34 7782301 1
2020-05-01 DEFA14A DEFA14A 0001047469-20-002759 000-29889 20840913 34 26736
2020-04-24 CT ORDER filename1.pdf 20200424,20200424 9999999997-20-002115 000-29889 20814986 34 122544
2020-04-24 CT ORDER filename1.pdf 20200424,20200424 9999999997-20-002114 000-29889 20814948 34 123264
2020-04-01 DEFA14A DEFA14A 0001104659-20-041947 000-29889 20766409 34 560175
2020-04-01 DEF 14A DEF 14A 0001047469-20-001990 000-29889 20766273 34 1344041
2020-02-27 8-K FORM 8-K 2.02,9.01 0001104659-20-026180 000-29889 20662225 34 103509
2020-02-27 10-K 10-K 0001558370-20-001624 000-29889 20661982 34 11592316 1
2020-02-18 SEC STAFF LETTER filename1.pdf 9999999997-20-000741 227280
2020-02-14 SC 13G/A RIGL_SC13GA1.htm 0001319244-20-000054 005-59985 20620311 34 143038
2020-02-11 SC 13G SCHEDULE 13G 0001104659-20-016449 005-59985 20597477 34 13607
2020-02-07 4 FORM 4 - 0001179110-20-001351 5352
2020-02-07 4 FORM 4 - 0001179110-20-001350 5174
2020-02-07 4 FORM 4 - 0001179110-20-001349 5303
2020-02-07 4 FORM 4 - 0001179110-20-001348 5301
2020-02-07 SC 13G/A filing.txt 0000315066-20-001146 005-59985 20585862 34 8681
2020-02-06 SC 13G/A us7665596034_020520.txt 0000834237-20-006820 005-59985 20581315 34 13256
2020-02-05 SEC STAFF LETTER filename1.pdf 9999999997-20-000517 231285
2020-01-27 SC 13G/A SEC SCHEDULE 13G 0000902219-20-000160 005-59985 20549497 34 37642
2020-01-16 CT ORDER filename1.pdf 20200116,20200116 9999999997-20-000139 333-45864 20530655 33 352612
2020-01-16 CT ORDER filename1.pdf 20200116,20200116 9999999997-20-000138 000-29889 20530334 34 121886
2020-01-16 CT ORDER filename1.pdf 20200116,20200116 9999999997-20-000137 000-29889 20530332 34 123035
2020-01-13 8-K FORM 8-K 2.02,9.01 0001104659-20-003446 000-29889 20523881 34 60438
2019-12-17 8-K FORM 8-K 5.02 0001104659-19-073467 000-29889 191290477 34 18298
2019-11-22 8-K 8-K 5.02,9.01 0001104659-19-066635 000-29889 191241546 34 31395
2019-11-20 4 FORM 4 - 0001179110-19-011948 5584
2019-11-20 4 FORM 4 - 0001179110-19-011946 5646
2019-11-20 4 FORM 4 - 0001179110-19-011944 5636
2019-11-20 4 FORM 4 - 0001179110-19-011942 5661
2019-11-20 4 FORM 4 - 0001179110-19-011940 5435
2019-11-20 4 FORM 4 - 0001179110-19-011938 5607
2019-11-20 4 FORM 4 - 0001179110-19-011937 5369
2019-11-18 8-K 8-K 8.01,9.01 0001104659-19-065084 000-29889 191227624 34 41464
2019-11-14 3 FORM 3 - 0001179110-19-011701 6296
2019-11-14 SC 13G RIGL_SC13G.htm 0001319244-19-000084 005-59985 191221201 34 143272
2019-11-05 10-Q 10-Q 0001558370-19-009974 000-29889 191193479 34 8608325 1
2019-11-05 8-K 8-K 2.02,9.01 0001104659-19-060054 000-29889 191193385 34 152132

Latest XBRL company facts

One latest value per concept from companyfacts (356 concepts). Full history stays in the JSON.

TaxonomyTagLabelUnitValueStartEndFYFPFormFiledAccn
dei EntityCommonStockSharesOutstanding Entity Common Stock, Shares Outstanding shares 18.83M 2026-11-02 2026 Q3 10-Q 2026-11-05 0001034842-26-000061
dei EntityPublicFloat Entity Public Float USD 331.60M 2025-06-30 2025 FY 10-K 2026-03-03 0001034842-26-000015
ffd NetFeeAmt NetFeeAmt USD 5,226.28 2026-08-04 S-8 2026-08-04 0001034842-26-000055
ffd TtlFeeAmt TtlFeeAmt USD 5,226.28 2026-08-04 S-8 2026-08-04 0001034842-26-000055
ffd TtlOfferingAmt TtlOfferingAmt USD 37.84M 2026-08-04 S-8 2026-08-04 0001034842-26-000055
ffd TtlOffsetAmt TtlOffsetAmt USD 0 2026-08-04 S-8 2026-08-04 0001034842-26-000055
us-gaap AccountsPayableAndAccruedLiabilitiesCurrent Accounts Payable and Accrued Liabilities, Current USD 12.69M 2021-12-31 2021 FY 10-K 2022-03-01 0001558370-22-002551
us-gaap AccountsPayableCurrent Accounts Payable, Current USD 11.44M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001034842-26-000061
us-gaap AccountsPayableTradeCurrent Accounts Payable, Trade, Current USD 5.90M 2021-12-31 2021 FY 10-K 2022-03-01 0001558370-22-002551
us-gaap AccountsReceivableNetCurrent Accounts Receivable, after Allowance for Credit Loss, Current USD 56.46M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001034842-26-000061
us-gaap AccretionExpense Accretion Expense USD 700,000 2023-01-01 2023-12-31 2023 FY 10-K 2024-03-05 0001558370-24-002475
us-gaap AccruedIncomeTaxesCurrent Accrued Income Taxes, Current USD 605,000 2021-12-31 2021 FY 10-K 2022-03-01 0001558370-22-002551
us-gaap AccruedLiabilitiesCurrent Accrued Liabilities, Current USD 3.58M 2021-12-31 2021 FY 10-K 2022-03-01 0001558370-22-002551
us-gaap AccruedProfessionalFeesCurrent Accrued Professional Fees, Current USD 204,000 2021-12-31 2021 FY 10-K 2022-03-01 0001558370-22-002551
us-gaap AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment USD 317,000 2025-12-31 2025 FY 10-K 2026-03-03 0001034842-26-000015
us-gaap AccumulatedDepreciationDepletionAndAmortizationSaleOfPropertyPlantAndEquipment Accumulated Depreciation, Depletion and Amortization, Sale or Disposal of Property, Plant and Equipment (Deprecated 2015-01-31) USD 6.50M 2015-01-01 2015-12-31 2015 FY 10-K 2016-03-08 0001558370-16-003898
us-gaap AccumulatedOtherComprehensiveIncomeLossNetOfTax Accumulated Other Comprehensive Income (Loss), Net of Tax USD -308,000 2026-09-30 2026 Q3 10-Q 2026-11-05 0001034842-26-000061
us-gaap AdditionalPaidInCapitalCommonStock Additional Paid in Capital, Common Stock USD 1.43B 2026-09-30 2026 Q3 10-Q 2026-11-05 0001034842-26-000061
us-gaap AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation Share-based Payment Arrangement, Decrease for Tax Withholding Obligation USD 5.30M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001034842-26-000061
us-gaap AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue APIC, Share-based Payment Arrangement, Increase for Cost Recognition USD 4.91M 2026-07-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001034842-26-000061
us-gaap AdjustmentsToAdditionalPaidInCapitalWarrantIssued Adjustments to Additional Paid in Capital, Warrant Issued USD 0 2011-01-01 2011-12-31 2011 FY 10-K 2012-03-06 0001047469-12-002146
us-gaap AdvancesOnInventoryPurchases Advances on Inventory Purchases USD 3.80M 2024-12-31 2024 FY 10-K 2025-03-04 0001558370-25-002169
us-gaap AdvertisingExpense Advertising Expense USD 2.30M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-03 0001034842-26-000015
us-gaap AllocatedShareBasedCompensationExpense Share-based Payment Arrangement, Expense USD 15.15M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001034842-26-000061
us-gaap AllowanceForDoubtfulAccountsReceivable Accounts Receivable, Allowance for Credit Loss USD 0 2020-12-31 2020 FY 10-K 2021-03-02 0001558370-21-002254
us-gaap AllowanceForDoubtfulAccountsReceivableCurrent Accounts Receivable, Allowance for Credit Loss, Current USD 0 2020-03-31 2020 Q1 10-Q 2020-05-05 0001558370-20-005179
us-gaap AmortizationOfIntangibleAssets Amortization of Intangible Assets USD 600,000 2026-01-01 2026-03-31 2026 Q1 10-Q 2026-05-05 0001034842-26-000032
us-gaap AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount shares 615,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001034842-26-000061
us-gaap AociDebtSecuritiesAvailableForSaleWithoutAllowanceForCreditLossCumulativeGainLossAfterTax AOCI, Debt Securities, Available-for-sale without Allowance for Credit Loss, Cumulative Gain (Loss), after Tax USD 10,000 2024-12-31 2024 FY 10-K 2025-03-04 0001558370-25-002169
us-gaap AreaOfRealEstateProperty Area of Real Estate Property sqft 9,328 2017-02-28 2021 FY 10-K 2022-03-01 0001558370-22-002551
us-gaap AssetAcquisitionContingentConsiderationLiability AssetAcquisitionContingentConsiderationLiability USD 5.00M 2025-09-30 2025 Q3 10-Q 2025-11-04 0001104659-25-106268
us-gaap AssetAcquisitionContingentConsiderationLiabilityCurrent AssetAcquisitionContingentConsiderationLiabilityCurrent USD 0 2026-09-30 2026 Q3 10-Q 2026-11-05 0001034842-26-000061
us-gaap AssetAcquisitionContingentConsiderationLiabilityNoncurrent AssetAcquisitionContingentConsiderationLiabilityNoncurrent USD 0 2025-12-31 2025 FY 10-K 2026-03-03 0001034842-26-000015
us-gaap Assets Assets USD 523.88M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001034842-26-000061
us-gaap AssetsCurrent Assets, Current USD 188.52M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001034842-26-000061
us-gaap AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax Debt Securities, Available-for-sale, Accumulated Gross Unrealized Gain, before Tax USD 1,000 2026-09-30 2026 Q3 10-Q 2026-11-05 0001034842-26-000061
us-gaap AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax Debt Securities, Available-for-sale, Accumulated Gross Unrealized Loss, before Tax USD 309,000 2026-09-30 2026 Q3 10-Q 2026-11-05 0001034842-26-000061
us-gaap AvailableForSaleDebtSecuritiesAmortizedCostBasis Debt Securities, Available-for-sale, Amortized Cost USD 108.95M 2025-09-30 2025 Q3 10-Q 2025-11-04 0001104659-25-106268
us-gaap AvailableForSaleSecurities Available-for-sale Securities USD 116.81M 2018-12-31 2018 FY 10-K 2019-02-28 0001558370-19-001310
us-gaap AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax Available-for-sale Securities, Accumulated Gross Unrealized Gain, before Tax USD 22,000 2019-03-31 2019 Q1 10-Q 2019-05-07 0001558370-19-004244
us-gaap AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax Available-for-sale Securities, Accumulated Gross Unrealized Loss, before Tax USD 12,000 2019-03-31 2019 Q1 10-Q 2019-05-07 0001558370-19-004244
us-gaap AvailableForSaleSecuritiesAmortizedCost Available-for-sale Securities, Amortized Cost Basis USD 116.28M 2019-03-31 2019 Q1 10-Q 2019-05-07 0001558370-19-004244
us-gaap AvailableForSaleSecuritiesContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss Available-for-sale Securities, Continuous Unrealized Loss Position, 12 Months or Longer, Accumulated Loss USD 2,000 2013-12-31 2014 FY 10-K 2015-03-03 0001047469-15-001563
us-gaap AvailableforsaleSecuritiesContinuousUnrealizedLossPosition12MonthsOrLongerAggregateLosses2 Available-for-sale Securities, Continuous Unrealized Loss Position, 12 Months or Longer, Aggregate Losses (Deprecated 2013-01-31) USD 0 2013-09-30 2013 Q3 10-Q 2013-11-05 0001104659-13-080831
us-gaap AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss Available-for-sale Securities, Continuous Unrealized Loss Position, Less than 12 Months, Accumulated Loss USD 27,000 2018-12-31 2018 FY 10-K 2019-02-28 0001558370-19-001310
us-gaap AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThan12MonthsAggregateLosses Available-for-sale Securities, Continuous Unrealized Loss Position, Less than 12 Months, Aggregate Loss (Deprecated 2018-01-31) USD 12,000 2019-01-01 2019-03-31 2019 Q1 10-Q 2019-05-07 0001558370-19-004244
us-gaap AvailableforsaleSecuritiesContinuousUnrealizedLossPositionLessThan12MonthsAggregateLosses2 Available-for-sale Securities, Continuous Unrealized Loss Position, Less than 12 Months, Aggregate Losses (Deprecated 2013-01-31) USD 8,000 2013-09-30 2013 Q3 10-Q 2013-11-05 0001104659-13-080831
us-gaap AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThanTwelveMonthsFairValue Available-for-sale Securities, Continuous Unrealized Loss Position, Less than Twelve Months, Fair Value USD 69.36M 2019-03-31 2019 Q1 10-Q 2019-05-07 0001558370-19-004244
us-gaap AvailableForSaleSecuritiesCurrent Available-for-sale Securities, Current USD 157.67M 2014-09-30 2014 Q3 10-Q 2014-11-04 0001104659-14-076408
us-gaap AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, Year One USD 95.91M 2016-03-31 2016 Q1 10-Q 2016-05-03 0001558370-16-005199
us-gaap AvailableForSaleSecuritiesDebtSecurities Debt Securities, Available-for-sale USD 73.14M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001034842-26-000061
us-gaap AvailableForSaleSecuritiesDebtSecuritiesCurrent Debt Securities, Available-for-sale, Current USD 51.70M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001034842-26-000061
us-gaap AvailableForSaleSecuritiesDebtSecuritiesNoncurrent Debt Securities, Available-for-sale, Noncurrent USD 21.40M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001034842-26-000061
us-gaap AvailableForSaleSecuritiesGrossUnrealizedGains Available-for-sale Securities, Gross Unrealized Gain USD 2,000 2018-01-01 2018-12-31 2018 FY 10-K 2019-02-28 0001558370-19-001310
us-gaap AvailableForSaleSecuritiesGrossUnrealizedLoss Available-for-sale Securities, Gross Unrealized Loss USD 27,000 2018-01-01 2018-12-31 2018 FY 10-K 2019-02-28 0001558370-19-001310
us-gaap AvailableForSaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositions Available-for-sale, Securities in Unrealized Loss Positions, Qualitative Disclosure, Number of Positions (Deprecated 2013-01-31) item 14 2013-09-30 2013 Q3 10-Q 2013-11-05 0001104659-13-080831
us-gaap AvailableforsaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositionsGreaterThanOrEqualToOneYear Available-for-sale, Securities in Unrealized Loss Positions, Qualitative Disclosure, Number of Positions, Greater than or Equal to One Year item 0 2019-03-31 2019 Q1 10-Q 2019-05-07 0001558370-19-004244
us-gaap AvailableForSaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositionsLessThanOneYear Available-for-sale, Securities in Unrealized Loss Positions, Qualitative Disclosure, Number of Positions, Less than One Year item 32 2019-03-31 2019 Q1 10-Q 2019-05-07 0001558370-19-004244
us-gaap CapitalExpendituresIncurredButNotYetPaid Capital Expenditures Incurred but Not yet Paid USD 2.50M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001034842-26-000061
us-gaap CapitalLeaseObligationsCurrent Capital Lease Obligations, Current USD 0 2011-12-31 2011 FY 10-K 2012-03-06 0001047469-12-002146
us-gaap CapitalLeaseObligationsNoncurrent Capital Lease Obligations, Noncurrent USD 0 2011-12-31 2011 FY 10-K 2012-03-06 0001047469-12-002146
us-gaap CashAndCashEquivalentsAtCarryingValue Cash and Cash Equivalents, at Carrying Value USD 46.65M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001034842-26-000061
us-gaap CashAndCashEquivalentsPeriodIncreaseDecrease Cash and Cash Equivalents, Period Increase (Decrease) USD -1.63M 2019-01-01 2019-03-31 2019 Q1 10-Q 2019-05-07 0001558370-19-004244
us-gaap CashCashEquivalentsAndShortTermInvestments Cash, Cash Equivalents, and Short-term Investments USD 99.36M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001034842-26-000061
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents USD 46.70M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001034842-26-000061
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect USD 6.07M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001034842-26-000061
us-gaap CommonStockCapitalSharesReservedForFutureIssuance Common Stock, Capital Shares Reserved for Future Issuance shares 27.26M 2020-12-31 2020 FY 10-K 2021-03-02 0001558370-21-002254
us-gaap CommonStockParOrStatedValuePerShare Common Stock, Par or Stated Value Per Share USD/shares 0.001 2025-12-31 2025 FY 10-K 2026-03-03 0001034842-26-000015
us-gaap CommonStockSharesAuthorized Common Stock, Shares Authorized shares 400.00M 2025-12-31 2025 FY 10-K 2026-03-03 0001034842-26-000015
us-gaap CommonStockSharesIssued Common Stock, Shares, Issued shares 18.31M 2025-12-31 2025 FY 10-K 2026-03-03 0001034842-26-000015
us-gaap CommonStockSharesOutstanding Common Stock, Shares, Outstanding shares 18.31M 2025-12-31 2025 FY 10-K 2026-03-03 0001034842-26-000015
us-gaap CommonStockValue Common Stock, Value, Issued USD 19,000 2026-09-30 2026 Q3 10-Q 2026-11-05 0001034842-26-000061
us-gaap ComprehensiveIncomeNetOfTax Comprehensive Income (Loss), Net of Tax, Attributable to Parent USD 38.64M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001034842-26-000061
us-gaap ContractsRevenue Contracts Revenue (Deprecated 2018-01-31) USD 4.48M 2017-01-01 2017-09-30 2018 Q3 10-Q 2018-11-06 0001558370-18-008624
us-gaap ContractWithCustomerLiability Contract with Customer, Liability USD 500,000 2018-06-30 2018 Q2 10-Q 2018-08-08 0001558370-18-006758
us-gaap ContractWithCustomerLiabilityCurrent Contract with Customer, Liability, Current USD 1.35M 2025-12-31 2025 FY 10-K 2026-03-03 0001034842-26-000015
us-gaap ContractWithCustomerLiabilityNoncurrent Contract with Customer, Liability, Noncurrent USD 1.40M 2019-12-31 2020 FY 10-K 2021-03-02 0001558370-21-002254
us-gaap ContractWithCustomerRefundLiability Contract with Customer, Refund Liability USD 46,000 2018-06-30 2018 Q2 10-Q 2018-08-08 0001558370-18-006758
us-gaap ContractWithCustomerRefundLiabilityCurrent Contract with Customer, Refund Liability, Current USD 26.81M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001034842-26-000061
us-gaap CostOfGoodsAndServicesSold Cost of Goods and Services Sold USD 23.91M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001034842-26-000061
us-gaap CostOfGoodsAndServicesSoldDepreciationAndAmortization Cost, Depreciation and Amortization USD 3.20M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001034842-26-000061
us-gaap CostsAndExpenses Costs and Expenses USD 165.85M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001034842-26-000061
us-gaap CurrentFederalTaxExpenseBenefit Current Federal Tax Expense (Benefit) USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-03 0001034842-26-000015
us-gaap CurrentForeignTaxExpenseBenefit Current Foreign Tax Expense (Benefit) USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-03 0001034842-26-000015
us-gaap CurrentIncomeTaxExpenseBenefit Current Income Tax Expense (Benefit) USD 655,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-03 0001034842-26-000015
us-gaap CurrentStateAndLocalTaxExpenseBenefit Current State and Local Tax Expense (Benefit) USD 655,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-03 0001034842-26-000015
us-gaap DebtInstrumentCarryingAmount Long-term Debt, Gross USD 8.00M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001034842-26-000061
us-gaap DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet Debt Instrument, Unamortized Discount (Premium) and Debt Issuance Costs, Net USD 600,000 2022-12-31 2023 Q3 10-Q 2023-11-07 0001558370-23-017987
us-gaap DebtSecuritiesAvailableForSaleAllowanceForCreditLossCurrent Debt Securities, Available-for-sale, Allowance for Credit Loss, Current USD 0 2025-12-31 2025 FY 10-K 2026-03-03 0001034842-26-000015
us-gaap DebtSecuritiesAvailableForSaleAmortizedCostAfterAllowanceForCreditLoss DebtSecuritiesAvailableForSaleAmortizedCostAfterAllowanceForCreditLoss USD 73.45M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001034842-26-000061
us-gaap DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, 12 Months or Longer, Number of Positions security 9 2025-12-31 2025 FY 10-K 2026-03-03 0001034842-26-000015
us-gaap DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, Less than 12 Months USD 67.03M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001034842-26-000061
us-gaap DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, Less than 12 Months, Accumulated Loss USD 309,000 2026-09-30 2026 Q3 10-Q 2026-11-05 0001034842-26-000061
us-gaap DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, Less than 12 Months, Number of Positions security 68 2026-09-30 2026 Q3 10-Q 2026-11-05 0001034842-26-000061
us-gaap DebtSecuritiesAvailableForSaleUnrealizedGainLoss Debt Securities, Available-for-sale, Unrealized Gain (Loss) USD 107,000 2025-01-01 2025-09-30 2025 Q3 10-Q 2025-11-04 0001104659-25-106268
us-gaap DeferredFederalIncomeTaxExpenseBenefit Deferred Federal Income Tax Expense (Benefit) USD -233.68M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-03 0001034842-26-000015
us-gaap DeferredFinanceCostsNet Debt Issuance Costs, Net USD 764,000 2026-09-30 2026 Q3 10-Q 2026-11-05 0001034842-26-000061
us-gaap DeferredForeignIncomeTaxExpenseBenefit Deferred Foreign Income Tax Expense (Benefit) USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-03 0001034842-26-000015
us-gaap DeferredIncomeTaxAssetsNet Deferred Income Tax Assets, Net USD 234.53M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001034842-26-000061
us-gaap DeferredIncomeTaxesAndTaxCredits Deferred Income Taxes and Tax Credits USD 11.32M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001034842-26-000061
us-gaap DeferredIncomeTaxExpenseBenefit Deferred Income Tax Expense (Benefit) USD -245.85M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-03 0001034842-26-000015
us-gaap DeferredRentAssetNetCurrent Deferred Rent Asset, Net, Current USD 30,000 2018-09-30 2018 Q3 10-Q 2018-11-06 0001558370-18-008624
us-gaap DeferredRentCreditCurrent Deferred Rent Credit, Current USD 2.80M 2016-12-31 2017 FY 10-K 2018-03-06 0001558370-18-001555
us-gaap DeferredRentCreditNoncurrent Deferred Rent Credit, Noncurrent USD 90,000 2018-12-31 2019 FY 10-K 2020-02-27 0001558370-20-001624
us-gaap DeferredRevenueCurrent Deferred Revenue, Current USD 13.43M 2015-12-31 2016 FY 10-K 2017-03-07 0001558370-17-001428
us-gaap DeferredRevenueNoncurrent Deferred Revenue, Noncurrent USD 3.76M 2015-06-30 2015 Q2 10-Q 2015-08-04 0001104659-15-055877
us-gaap DeferredStateAndLocalIncomeTaxExpenseBenefit Deferred State and Local Income Tax Expense (Benefit) USD -12.17M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-03 0001034842-26-000015
us-gaap DeferredTaxAssetsDeferredIncome Deferred Tax Assets, Deferred Income USD 334,000 2025-12-31 2025 FY 10-K 2026-03-03 0001034842-26-000015
us-gaap DeferredTaxAssetsGross Deferred Tax Assets, Gross USD 292.55M 2025-12-31 2025 FY 10-K 2026-03-03 0001034842-26-000015
us-gaap DeferredTaxAssetsInventory Deferred Tax Assets, Inventory USD 47,000 2021-12-31 2021 FY 10-K 2022-03-01 0001558370-22-002551
us-gaap DeferredTaxAssetsNet Deferred Tax Assets, Net of Valuation Allowance USD 245.85M 2025-12-31 2025 FY 10-K 2026-03-03 0001034842-26-000015
us-gaap DeferredTaxAssetsOperatingLossCarryforwards Deferred Tax Assets, Operating Loss Carryforwards USD 216.01M 2025-12-31 2025 FY 10-K 2026-03-03 0001034842-26-000015
us-gaap DeferredTaxAssetsOther Deferred Tax Assets, Other USD 3.30M 2025-12-31 2025 FY 10-K 2026-03-03 0001034842-26-000015
us-gaap DeferredTaxAssetsTaxCreditCarryforwardsResearch Deferred Tax Assets, Tax Credit Carryforwards, Research USD 63.46M 2025-12-31 2025 FY 10-K 2026-03-03 0001034842-26-000015
us-gaap DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Employee Compensation USD 4.62M 2025-12-31 2025 FY 10-K 2026-03-03 0001034842-26-000015
us-gaap DeferredTaxAssetsValuationAllowance Deferred Tax Assets, Valuation Allowance USD 46.70M 2025-12-31 2025 FY 10-K 2026-03-03 0001034842-26-000015
us-gaap DeferredTaxLiabilitiesOther Deferred Tax Liabilities, Other USD 327,000 2025-12-31 2025 FY 10-K 2026-03-03 0001034842-26-000015
us-gaap DepreciationDepletionAndAmortization Depreciation, Depletion and Amortization USD 3.24M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001034842-26-000061
us-gaap EarningsPerShareBasic Earnings Per Share, Basic USD/shares 2.11 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001034842-26-000061
us-gaap EarningsPerShareBasicAndDiluted Earnings Per Share, Basic and Diluted USD/shares -0.18 2020-01-01 2020-12-31 2020 FY 10-K 2021-03-02 0001558370-21-002254
us-gaap EarningsPerShareDiluted Earnings Per Share, Diluted USD/shares 1.97 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001034842-26-000061
us-gaap EffectiveIncomeTaxRateContinuingOperations Effective Income Tax Rate Reconciliation, Percent pure -2.013 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-03 0001034842-26-000015
us-gaap EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent pure 0.21 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-03 0001034842-26-000015
us-gaap EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent pure -2.181 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-03 0001034842-26-000015
us-gaap EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate Effective Income Tax Rate Reconciliation, Change in Enacted Tax Rate, Percent pure 1.602 2017-01-01 2017-12-31 2019 FY 10-K 2020-02-27 0001558370-20-001624
us-gaap EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Percent pure 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-03 0001034842-26-000015
us-gaap EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Percent pure 0.059 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-03 0001034842-26-000015
us-gaap EffectiveIncomeTaxRateReconciliationOtherAdjustments Effective Income Tax Rate Reconciliation, Other Adjustments, Percent pure 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-03 0001034842-26-000015
us-gaap EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent pure -0.095 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-03 0001034842-26-000015
us-gaap EffectiveIncomeTaxRateReconciliationTaxContingencies Effective Income Tax Rate Reconciliation, Tax Contingency, Percent pure 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-03 0001034842-26-000015
us-gaap EffectiveIncomeTaxRateReconciliationTaxContingenciesForeign Effective Income Tax Rate Reconciliation, Tax Contingency, Foreign, Percent pure 0.032 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-04 0001558370-25-002169
us-gaap EffectiveIncomeTaxRateReconciliationTaxCreditsResearch Effective Income Tax Rate Reconciliation, Tax Credit, Research, Percent pure 0.006 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-03 0001034842-26-000015
us-gaap EmployeeRelatedLiabilitiesCurrent Employee-related Liabilities, Current USD 10.13M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001034842-26-000061
us-gaap EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount USD 14.70M 2025-12-31 2025 FY 10-K 2026-03-03 0001034842-26-000015
us-gaap EmployeeServiceShareBasedCompensationTaxBenefitRealizedFromExerciseOfStockOptions Employee Service Share-based Compensation, Tax Benefit Realized from Exercise of Stock Options (Deprecated 2017-01-31) USD 2.50M 2016-12-31 2016 FY 10-K 2017-03-07 0001558370-17-001428
us-gaap EquityIssuancePerShareAmount Development Stage Entities, Equity Issuance, Per Share Amount (Deprecated 2015-01-31) USD 9.5 2012-01-01 2012-12-31 2014 FY 10-K 2015-03-03 0001047469-15-001563
us-gaap FairValueOfAssetsAcquired Fair Value of Assets Acquired USD 5.00M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-03 0001034842-26-000015
us-gaap FiniteLivedIntangibleAssetsAccumulatedAmortization Finite-Lived Intangible Assets, Accumulated Amortization USD 8.84M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001034842-26-000061
us-gaap FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive Finite-Lived Intangible Asset, Expected Amortization, after Year Five USD 12.99M 2025-12-31 2025 FY 10-K 2026-03-03 0001034842-26-000015
us-gaap FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths Finite-Lived Intangible Asset, Expected Amortization, Year One USD 7.22M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001034842-26-000061
us-gaap FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear Finite-Lived Intangible Asset, Expected Amortization, Remainder of Fiscal Year USD 1.81M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001034842-26-000061
us-gaap FiniteLivedIntangibleAssetsAmortizationExpenseYearFive Finite-Lived Intangible Asset, Expected Amortization, Year Five USD 2.35M 2025-12-31 2025 FY 10-K 2026-03-03 0001034842-26-000015
us-gaap FiniteLivedIntangibleAssetsAmortizationExpenseYearFour Finite-Lived Intangible Asset, Expected Amortization, Year Four USD 7.22M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001034842-26-000061
us-gaap FiniteLivedIntangibleAssetsAmortizationExpenseYearThree Finite-Lived Intangible Asset, Expected Amortization, Year Three USD 7.22M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001034842-26-000061
us-gaap FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo Finite-Lived Intangible Asset, Expected Amortization, Year Two USD 7.22M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001034842-26-000061
us-gaap FiniteLivedIntangibleAssetsGross Finite-Lived Intangible Assets, Gross USD 103.42M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001034842-26-000061
us-gaap FiniteLivedIntangibleAssetsNet Finite-Lived Intangible Assets, Net USD 94.59M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001034842-26-000061
us-gaap ForeignIncomeTaxExpenseBenefitContinuingOperations Foreign Income Tax Expense (Benefit), Continuing Operations USD 0 2023-01-01 2023-12-31 2024 FY 10-K 2025-03-04 0001558370-25-002169
us-gaap GainLossOnDispositionOfAssets1 Gain (Loss) on Disposition of Assets USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-03 0001034842-26-000015
us-gaap GainsLossesOnExtinguishmentOfDebt Gain (Loss) on Extinguishment of Debt USD -209,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001034842-26-000061
us-gaap GeneralAndAdministrativeExpense General and Administrative Expense USD 48.63M 2018-01-01 2018-09-30 2018 Q3 10-Q 2018-11-06 0001558370-18-008624
us-gaap GrossProfit Gross Profit USD 17.43M 2020-10-01 2020-12-31 2020 FY 10-K 2021-03-02 0001558370-21-002254
us-gaap HeldToMaturitySecuritiesDebtMaturitiesWithinOneYearNetCarryingAmount Debt Securities, Held-to-Maturity, Amortized Cost, Maturity, Allocated and Single Maturity Date, Year One USD 93.57M 2015-12-31 2015 FY 10-K 2016-03-08 0001558370-16-003898
us-gaap ImpairmentOfLongLivedAssetsToBeDisposedOf Impairment of Long-Lived Assets to be Disposed of USD 700,000 2022-01-01 2022-12-31 2022 FY 10-K 2023-03-07 0001558370-23-003035
us-gaap IncentiveToLessee Incentive to Lessee USD 600,000 2021-12-31 2021 FY 10-K 2022-03-01 0001558370-22-002551
us-gaap IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest USD 52.65M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001034842-26-000061
us-gaap IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Noncontrolling Interest USD -85.97M 2011-01-01 2011-12-31 2011 FY 10-K 2012-03-06 0001047469-12-002146
us-gaap IncomeTaxesPaidNet Income Taxes Paid, Net USD 1.06M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-03 0001034842-26-000015
us-gaap IncomeTaxExpenseBenefit Income Tax Expense (Benefit) USD 13.52M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001034842-26-000061
us-gaap IncomeTaxExpenseBenefitContinuingOperations Income Tax Expense (Benefit), Continuing Operations (Deprecated 2013-01-31) USD 0 2011-01-01 2011-12-31 2011 FY 10-K 2012-03-06 0001047469-12-002146
us-gaap IncomeTaxPaidFederalAfterRefundReceived IncomeTaxPaidFederalAfterRefundReceived USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-03 0001034842-26-000015
us-gaap IncomeTaxPaidStateAndLocalAfterRefundReceived IncomeTaxPaidStateAndLocalAfterRefundReceived USD 463,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-03 0001034842-26-000015
us-gaap IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount USD -265.78M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-03 0001034842-26-000015
us-gaap IncomeTaxReconciliationForeignIncomeTaxRateDifferential Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Amount USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-03 0001034842-26-000015
us-gaap IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount USD 25.59M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-03 0001034842-26-000015
us-gaap IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Amount USD 7.30M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-03 0001034842-26-000015
us-gaap IncomeTaxReconciliationOtherAdjustments Effective Income Tax Rate Reconciliation, Other Adjustments, Amount USD 38,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-03 0001034842-26-000015
us-gaap IncomeTaxReconciliationStateAndLocalIncomeTaxes Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Amount USD -11.52M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-03 0001034842-26-000015
us-gaap IncomeTaxReconciliationTaxContingencies Effective Income Tax Rate Reconciliation, Tax Contingency, Amount USD -82,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-03 0001034842-26-000015
us-gaap IncomeTaxReconciliationTaxCreditsResearch Effective Income Tax Rate Reconciliation, Tax Credit, Research, Amount USD 744,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-03 0001034842-26-000015
us-gaap IncreaseDecreaseInAccountsPayable Increase (Decrease) in Accounts Payable USD 1.75M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001034842-26-000061
us-gaap IncreaseDecreaseInAccountsReceivable Increase (Decrease) in Accounts Receivable USD 4.70M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001034842-26-000061
us-gaap IncreaseDecreaseInContractWithCustomerLiability Increase (Decrease) in Contract with Customer, Liability USD -14,000 2023-01-01 2023-12-31 2024 FY 10-K 2025-03-04 0001558370-25-002169
us-gaap IncreaseDecreaseInDeferredRevenue Increase (Decrease) in Deferred Revenue USD 2.44M 2018-01-01 2018-12-31 2018 FY 10-K 2019-02-28 0001558370-19-001310
us-gaap IncreaseDecreaseInEmployeeRelatedLiabilities Increase (Decrease) in Employee Related Liabilities USD -1.79M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001034842-26-000061
us-gaap IncreaseDecreaseInInventories Increase (Decrease) in Inventories USD 8.02M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001034842-26-000061
us-gaap IncreaseDecreaseInOperatingLeaseLiability IncreaseDecreaseInOperatingLeaseLiability USD -453,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001034842-26-000061
us-gaap IncreaseDecreaseInOtherAccruedLiabilities Increase (Decrease) in Other Accrued Liabilities USD 1.80M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001034842-26-000061
us-gaap IncreaseDecreaseInOtherNoncurrentAssets Increase (Decrease) in Other Noncurrent Assets USD -98,000 2023-01-01 2023-03-31 2024 Q1 10-Q 2024-05-07 0001558370-24-007041
us-gaap IncreaseDecreaseInOtherNoncurrentLiabilities Increase (Decrease) in Other Noncurrent Liabilities USD 5.10M 2019-01-01 2019-12-31 2021 FY 10-K 2022-03-01 0001558370-22-002551
us-gaap IncreaseDecreaseInOtherOperatingLiabilities Increase (Decrease) in Other Operating Liabilities USD -285,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-03 0001034842-26-000015
us-gaap IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets Increase (Decrease) in Prepaid Expense and Other Assets USD -5.01M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001034842-26-000061
us-gaap IncreaseDecreaseInReceivables Increase (Decrease) in Receivables USD 0 2011-01-01 2011-09-30 2011 Q3 10-Q 2011-11-01 0001104659-11-059341
us-gaap IntangibleAssetsNetIncludingGoodwill Intangible Assets, Net (Including Goodwill) USD 94.59M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001034842-26-000061
us-gaap InterestExpense Interest Expense USD 5.62M 2025-01-01 2025-09-30 2025 Q3 10-Q 2025-11-04 0001104659-25-106268
us-gaap InterestExpenseDebt Interest Expense, Debt USD 2.50M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001034842-26-000061
us-gaap InterestExpenseNonoperating InterestExpenseNonoperating USD 2.47M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001034842-26-000061
us-gaap InterestPaid Interest Paid, Including Capitalized Interest, Operating and Investing Activities USD 21,000 2011-01-01 2011-12-31 2013 FY 10-K 2014-03-04 0001047469-14-001756
us-gaap InterestPaidNet Interest Paid, Excluding Capitalized Interest, Operating Activities USD 5.17M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001034842-26-000061
us-gaap InterestPayableCurrent Interest Payable, Current USD 387,000 2021-12-31 2021 FY 10-K 2022-03-01 0001558370-22-002551
us-gaap InterestReceivableCurrent Interest Receivable, Current USD 400,000 2026-09-30 2026 Q3 10-Q 2026-11-05 0001034842-26-000061
us-gaap InventoryFinishedGoods Inventory, Finished Goods, Gross USD 7.20M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001034842-26-000061
us-gaap InventoryNet Inventory, Net USD 15.80M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001034842-26-000061
us-gaap InventoryRawMaterials Inventory, Raw Materials, Gross USD 7.33M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001034842-26-000061
us-gaap InventoryValuationReserves Inventory Valuation Reserves USD 94,000 2018-12-31 2018 FY 10-K 2019-02-28 0001558370-19-001310
us-gaap InventoryWorkInProcess Inventory, Work in Process, Gross USD 6.77M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001034842-26-000061
us-gaap InvestmentIncomeInterest Investment Income, Interest USD 2.56M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001034842-26-000061
us-gaap InvestmentIncomeNetAmortizationOfDiscountAndPremium Investment Income, Net, Amortization of Discount and Premium USD 240,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001034842-26-000061
us-gaap InvestmentsAndCash Investments and Cash USD 99.30M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001034842-26-000061
us-gaap InvestmentsFairValueDisclosure Investments, Fair Value Disclosure USD 85.93M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001034842-26-000061
us-gaap IssuanceOfStockAndWarrantsForServicesOrClaims Issuance of Stock and Warrants for Services or Claims USD 0 2011-01-01 2011-12-31 2011 FY 10-K 2012-03-06 0001047469-12-002146
us-gaap LeaseCost Lease, Cost USD 706,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-03 0001034842-26-000015
us-gaap LesseeOperatingLeaseLiabilityPaymentsDue Lessee, Operating Lease, Liability, to be Paid USD 600,000 2026-09-30 2026 Q3 10-Q 2026-11-05 0001034842-26-000061
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths Lessee, Operating Lease, Liability, to be Paid, Year One USD 692,000 2025-12-31 2025 FY 10-K 2026-03-03 0001034842-26-000015
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearFive Lessee, Operating Lease, Liability, to be Paid, Year Five USD 877,000 2019-09-30 2019 Q3 10-Q 2019-11-05 0001558370-19-009974
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearFour Lessee, Operating Lease, Liability, to be Paid, Year Four USD 877,000 2020-09-30 2020 Q3 10-Q 2020-11-05 0001558370-20-012838
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearThree Lessee, Operating Lease, Liability, to be Paid, Year Three USD 301,000 2022-12-31 2022 FY 10-K 2023-03-07 0001558370-23-003035
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearTwo Lessee, Operating Lease, Liability, to be Paid, Year Two USD 409,000 2025-12-31 2025 FY 10-K 2026-03-03 0001034842-26-000015
us-gaap LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year USD 170,000 2025-09-30 2025 Q3 10-Q 2025-11-04 0001104659-25-106268
us-gaap LesseeOperatingLeaseLiabilityUndiscountedExcessAmount Lessee, Operating Lease, Liability, Undiscounted Excess Amount USD 2.61M 2020-09-30 2020 Q3 10-Q 2020-11-05 0001558370-20-012838
us-gaap Liabilities Liabilities USD 78.77M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001034842-26-000061
us-gaap LiabilitiesAndStockholdersEquity Liabilities and Equity USD 523.88M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001034842-26-000061
us-gaap LiabilitiesAssumed1 Liabilities Assumed USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001034842-26-000061
us-gaap LiabilitiesCurrent Liabilities, Current USD 78.77M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001034842-26-000061
us-gaap LineOfCreditFacilityIncreaseAccruedInterest Line of Credit Facility, Increase, Accrued Interest USD 100,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001034842-26-000061
us-gaap LoansPayable Loans Payable USD 7.24M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001034842-26-000061
us-gaap LoansPayableCurrent Loans Payable, Current USD 7.24M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001034842-26-000061
us-gaap LongTermDebt Long-term Debt USD 45.00M 2026-03-31 2026 Q1 10-Q 2026-05-05 0001034842-26-000032
us-gaap LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths Long-Term Debt, Maturity, Year One USD 22.50M 2026-03-31 2026 Q1 10-Q 2026-05-05 0001034842-26-000032
us-gaap LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive Long-Term Debt, Maturity, Year Five USD 5.00M 2020-12-31 2020 FY 10-K 2021-03-02 0001558370-21-002254
us-gaap LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour Long-Term Debt, Maturity, Year Four USD 22.50M 2023-12-31 2023 FY 10-K 2024-03-05 0001558370-24-002475
us-gaap LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree Long-Term Debt, Maturity, Year Three USD 22.50M 2024-12-31 2024 FY 10-K 2025-03-04 0001558370-25-002169
us-gaap LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo Long-Term Debt, Maturity, Year Two USD 22.50M 2025-12-31 2025 FY 10-K 2026-03-03 0001034842-26-000015
us-gaap LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear Long-Term Debt, Maturity, Remainder of Fiscal Year USD 22.50M 2026-03-31 2026 Q1 10-Q 2026-05-05 0001034842-26-000032
us-gaap LongTermLoansPayable Loans Payable, Noncurrent USD 0 2026-09-30 2026 Q3 10-Q 2026-11-05 0001034842-26-000061
us-gaap NetCashProvidedByUsedInContinuingOperations Net Cash Provided by (Used in) Continuing Operations USD 22.51M 2017-01-01 2017-03-31 2017 Q1 10-Q 2017-05-02 0001558370-17-003254
us-gaap NetCashProvidedByUsedInFinancingActivities Net Cash Provided by (Used in) Financing Activities USD -52.91M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001034842-26-000061
us-gaap NetCashProvidedByUsedInFinancingActivitiesContinuingOperations Net Cash Provided by (Used in) Financing Activities, Continuing Operations USD 43.42M 2017-01-01 2017-03-31 2017 Q1 10-Q 2017-05-02 0001558370-17-003254
us-gaap NetCashProvidedByUsedInInvestingActivities Net Cash Provided by (Used in) Investing Activities USD -8.97M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001034842-26-000061
us-gaap NetCashProvidedByUsedInInvestingActivitiesContinuingOperations Net Cash Provided by (Used in) Investing Activities, Continuing Operations USD -150,000 2017-01-01 2017-03-31 2017 Q1 10-Q 2017-05-02 0001558370-17-003254
us-gaap NetCashProvidedByUsedInOperatingActivities Net Cash Provided by (Used in) Operating Activities USD 67.94M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001034842-26-000061
us-gaap NetCashProvidedByUsedInOperatingActivitiesContinuingOperations Net Cash Provided by (Used in) Operating Activities, Continuing Operations USD -20.76M 2017-01-01 2017-03-31 2017 Q1 10-Q 2017-05-02 0001558370-17-003254
us-gaap NetIncomeLoss Net Income (Loss) Attributable to Parent USD 39.13M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001034842-26-000061
us-gaap NetIncomeLossAvailableToCommonStockholdersBasic Net Income (Loss) Available to Common Stockholders, Basic USD 367.02M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-03 0001034842-26-000015
us-gaap NumberOfOperatingSegments Number of Operating Segments segment 1 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-03 0001034842-26-000015
us-gaap NumberOfReportableSegments Number of Reportable Segments segment 1 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001034842-26-000061
us-gaap OperatingIncomeLoss Operating Income (Loss) USD 52.56M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001034842-26-000061
us-gaap OperatingLeaseCost Operating Lease, Cost USD 200,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001034842-26-000061
us-gaap OperatingLeaseExpense Operating Lease, Expense USD 5.84M 2020-01-01 2020-09-30 2020 Q3 10-Q 2020-11-05 0001558370-20-012838
us-gaap OperatingLeaseLiability Operating Lease, Liability USD 8.30M 2022-03-31 2022 Q1 10-Q 2022-05-03 0001558370-22-006809
us-gaap OperatingLeaseLiabilityCurrent Operating Lease, Liability, Current USD 556,000 2026-09-30 2026 Q3 10-Q 2026-11-05 0001034842-26-000061
us-gaap OperatingLeaseLiabilityNoncurrent Operating Lease, Liability, Noncurrent USD 0 2026-09-30 2026 Q3 10-Q 2026-11-05 0001034842-26-000061
us-gaap OperatingLeasePayments Operating Lease, Payments USD 500,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001034842-26-000061
us-gaap OperatingLeaseRightOfUseAsset Operating Lease, Right-of-Use Asset USD 504,000 2026-09-30 2026 Q3 10-Q 2026-11-05 0001034842-26-000061
us-gaap OperatingLeasesFutureMinimumPaymentsDue Operating Leases, Future Minimum Payments Due USD 40.46M 2018-12-31 2018 FY 10-K 2019-02-28 0001558370-19-001310
us-gaap OperatingLeasesFutureMinimumPaymentsDueCurrent Operating Leases, Future Minimum Payments Due, Next Twelve Months USD 9.32M 2018-12-31 2018 FY 10-K 2019-02-28 0001558370-19-001310
us-gaap OperatingLeasesFutureMinimumPaymentsDueInFiveYears Operating Leases, Future Minimum Payments, Due in Five Years USD 877,000 2018-12-31 2018 FY 10-K 2019-02-28 0001558370-19-001310
us-gaap OperatingLeasesFutureMinimumPaymentsDueInFourYears Operating Leases, Future Minimum Payments, Due in Four Years USD 10.48M 2018-12-31 2018 FY 10-K 2019-02-28 0001558370-19-001310
us-gaap OperatingLeasesFutureMinimumPaymentsDueInThreeYears Operating Leases, Future Minimum Payments, Due in Three Years USD 10.08M 2018-12-31 2018 FY 10-K 2019-02-28 0001558370-19-001310
us-gaap OperatingLeasesFutureMinimumPaymentsDueInTwoYears Operating Leases, Future Minimum Payments, Due in Two Years USD 9.69M 2018-12-31 2018 FY 10-K 2019-02-28 0001558370-19-001310
us-gaap OperatingLeasesFutureMinimumPaymentsDueThereafter Operating Leases, Future Minimum Payments, Due Thereafter USD 11.36M 2017-12-31 2017 FY 10-K 2018-03-06 0001558370-18-001555
us-gaap OperatingLeasesFutureMinimumPaymentsReceivable Operating Leases, Future Minimum Payments Receivable USD 18.20M 2018-12-31 2018 FY 10-K 2019-02-28 0001558370-19-001310
us-gaap OperatingLeasesFutureMinimumPaymentsReceivableCurrent Operating Leases, Future Minimum Payments Receivable, Current USD 4.19M 2018-12-31 2018 FY 10-K 2019-02-28 0001558370-19-001310
us-gaap OperatingLeasesFutureMinimumPaymentsReceivableInFiveYears Operating Leases, Future Minimum Payments Receivable, in Five Years USD 394,000 2018-12-31 2018 FY 10-K 2019-02-28 0001558370-19-001310
us-gaap OperatingLeasesFutureMinimumPaymentsReceivableInFourYears Operating Leases, Future Minimum Payments Receivable, in Four Years USD 4.72M 2018-12-31 2018 FY 10-K 2019-02-28 0001558370-19-001310
us-gaap OperatingLeasesFutureMinimumPaymentsReceivableInThreeYears Operating Leases, Future Minimum Payments Receivable, in Three Years USD 4.53M 2018-12-31 2018 FY 10-K 2019-02-28 0001558370-19-001310
us-gaap OperatingLeasesFutureMinimumPaymentsReceivableInTwoYears Operating Leases, Future Minimum Payments Receivable, in Two Years USD 4.36M 2018-12-31 2018 FY 10-K 2019-02-28 0001558370-19-001310
us-gaap OperatingLeasesFutureMinimumPaymentsReceivableThereafter Operating Leases, Future Minimum Payments Receivable, Thereafter USD 5.11M 2017-12-31 2017 FY 10-K 2018-03-06 0001558370-18-001555
us-gaap OperatingLeasesRentExpenseNet Operating Leases, Rent Expense, Net USD 6.00M 2018-01-01 2018-12-31 2018 FY 10-K 2019-02-28 0001558370-19-001310
us-gaap OtherAccruedLiabilitiesCurrent Other Accrued Liabilities, Current USD 11.07M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001034842-26-000061
us-gaap OtherAssetsCurrent Other Assets, Current USD 6.49M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001034842-26-000061
us-gaap OtherAssetsNoncurrent Other Assets, Noncurrent USD 5.74M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001034842-26-000061
us-gaap OtherComprehensiveIncomeAvailableForSaleSecuritiesAdjustmentNetOfTaxPeriodIncreaseDecrease Other Comprehensive Income (Loss), Available-for-sale Securities Adjustment, Net of Tax (Deprecated 2012-01-31) USD 44,000 2011-01-01 2011-12-31 2011 FY 10-K 2012-03-06 0001047469-12-002146
us-gaap OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent Other Comprehensive Income (Loss), Available-for-sale Securities Adjustment, Net of Tax, Portion Attributable to Parent USD -489,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001034842-26-000061
us-gaap OtherLiabilitiesCurrent Other Liabilities, Current USD 11.47M 2025-12-31 2025 FY 10-K 2026-03-03 0001034842-26-000015
us-gaap OtherLiabilitiesNoncurrent Other Liabilities, Noncurrent USD 0 2025-12-31 2025 FY 10-K 2026-03-03 0001034842-26-000015
us-gaap OtherNonoperatingIncome Other Nonoperating Income USD 2.36M 2010-01-01 2010-12-31 2012 FY 10-K 2013-03-05 0001047469-13-002185
us-gaap OtherRestrictedAssetsCurrent Other Restricted Assets, Current USD 57,000 2025-09-30 2025 Q3 10-Q 2025-11-04 0001104659-25-106268
us-gaap OtherThanTemporaryImpairmentCreditLossesRecognizedInEarningsCreditLossesOnDebtSecuritiesHeld Other than Temporary Impairment, Credit Losses Recognized in Earnings, Credit Losses on Debt Securities Held USD 0 2023-09-30 2023 Q3 10-Q 2023-11-07 0001558370-23-017987
us-gaap OtherThanTemporaryImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings Other-than-temporary Impairment Loss, Debt Securities, Available-for-sale, Recognized in Earnings USD 0 2021-01-01 2021-12-31 2021 FY 10-K 2022-03-01 0001558370-22-002551
us-gaap OtherThanTemporaryImpairmentLossesInvestmentsAvailableforsaleSecurities Other than Temporary Impairment Losses, Investments, Available-for-sale Securities USD 0 2019-01-01 2019-03-31 2019 Q1 10-Q 2019-05-07 0001558370-19-004244
us-gaap PaymentForContingentConsiderationLiabilityFinancingActivities Payment for Contingent Consideration Liability, Financing Activities USD 5.00M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001034842-26-000061
us-gaap PaymentsForPostemploymentBenefits Payments for Postemployment Benefits USD 180,000 2016-01-01 2016-03-31 2016 Q1 10-Q 2016-05-03 0001558370-16-005199
us-gaap PaymentsForRepurchaseOfCommonStock Payments for Repurchase of Common Stock USD 5.28M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001034842-26-000061
us-gaap PaymentsForRestructuring Payments for Restructuring USD 5.00M 2016-01-01 2016-12-31 2018 FY 10-K 2019-02-28 0001558370-19-001310
us-gaap PaymentsOfDebtIssuanceCosts Payments of Debt Issuance Costs USD 345,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001034842-26-000061
us-gaap PaymentsToAcquireAvailableForSaleSecurities Payments to Acquire Available-for-sale Securities USD 171.66M 2014-01-01 2014-09-30 2014 Q3 10-Q 2014-11-04 0001104659-14-076408
us-gaap PaymentsToAcquireIntangibleAssets Payments to Acquire Intangible Assets USD 70.56M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001034842-26-000061
us-gaap PaymentsToAcquirePropertyPlantAndEquipment Payments to Acquire Property, Plant, and Equipment USD 450,000 2022-01-01 2022-12-31 2023 FY 10-K 2024-03-05 0001558370-24-002475
us-gaap PaymentsToAcquireShortTermInvestments Payments to Acquire Short-term Investments USD 55.03M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001034842-26-000061
us-gaap PreferredStockParOrStatedValuePerShare Preferred Stock, Par or Stated Value Per Share USD/shares 0.001 2025-12-31 2025 FY 10-K 2026-03-03 0001034842-26-000015
us-gaap PreferredStockSharesAuthorized Preferred Stock, Shares Authorized shares 10.00M 2025-12-31 2025 FY 10-K 2026-03-03 0001034842-26-000015
us-gaap PreferredStockSharesIssued Preferred Stock, Shares Issued shares 0 2025-12-31 2025 FY 10-K 2026-03-03 0001034842-26-000015
us-gaap PreferredStockSharesOutstanding Preferred Stock, Shares Outstanding shares 0 2025-12-31 2025 FY 10-K 2026-03-03 0001034842-26-000015
us-gaap PreferredStockValue Preferred Stock, Value, Issued USD 0 2025-12-31 2025 FY 10-K 2026-03-03 0001034842-26-000015
us-gaap PrepaidExpenseAndOtherAssetsCurrent Prepaid Expense and Other Assets, Current USD 16.96M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001034842-26-000061
us-gaap ProceedsFromIncomeTaxRefunds Proceeds from Income Tax Refunds USD 98,000 2010-01-01 2010-12-31 2012 FY 10-K 2013-03-05 0001047469-13-002185
us-gaap ProceedsFromIssuanceOfCommonStock Proceeds from Issuance of Common Stock USD 67.16M 2018-01-01 2018-12-31 2020 FY 10-K 2021-03-02 0001558370-21-002254
us-gaap ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions Proceeds, Issuance of Shares, Share-based Payment Arrangement, Including Option Exercised USD 4.96M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001034842-26-000061
us-gaap ProceedsFromLinesOfCredit Proceeds from Lines of Credit USD 40.00M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001034842-26-000061
us-gaap ProceedsFromLongTermLinesOfCredit Proceeds from Long-term Lines of Credit USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-03 0001034842-26-000015
us-gaap ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities Proceeds from Maturities, Prepayments and Calls of Debt Securities, Available-for-sale USD 217.89M 2014-01-01 2014-09-30 2014 Q3 10-Q 2014-11-04 0001104659-14-076408
us-gaap ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments Proceeds from Maturities, Prepayments and Calls of Short-term Investments USD 36.70M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001034842-26-000061
us-gaap ProceedsFromRepaymentsOfLinesOfCredit Proceeds from (Repayments of) Lines of Credit USD 40.00M 2026-01-01 2026-06-30 2026 Q2 10-Q 2026-08-04 0001034842-26-000052
us-gaap ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities Proceeds from Sale and Maturity of Debt Securities, Available-for-sale USD 127.40M 2013-01-01 2013-03-31 2013 Q1 10-Q 2013-05-07 0001104659-13-038074
us-gaap ProceedsFromSaleOfAvailableForSaleSecurities Proceeds from Sale of Available-for-sale Securities USD 16.48M 2013-01-01 2013-09-30 2014 Q3 10-Q 2014-11-04 0001104659-14-076408
us-gaap ProceedsFromSaleOfPropertyPlantAndEquipment Proceeds from Sale of Property, Plant, and Equipment USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-03 0001034842-26-000015
us-gaap ProceedsFromSaleOfShortTermInvestments Proceeds from Sale of Short-term Investments USD 79.93M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001034842-26-000061
us-gaap ProfessionalFees Professional Fees USD 1.50M 2018-01-01 2018-03-31 2018 Q1 10-Q 2018-05-01 0001558370-18-003644
us-gaap ProfitLoss Net Income (Loss), Including Portion Attributable to Noncontrolling Interest USD 39.13M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001034842-26-000061
us-gaap PropertyPlantAndEquipmentDisposals Property, Plant and Equipment, Disposals USD 86,000 2020-01-01 2020-12-31 2020 FY 10-K 2021-03-02 0001558370-21-002254
us-gaap PropertyPlantAndEquipmentGross Property, Plant and Equipment, Gross USD 347,000 2025-12-31 2025 FY 10-K 2026-03-03 0001034842-26-000015
us-gaap PropertyPlantAndEquipmentNet Property, Plant and Equipment, Net USD 30,000 2025-12-31 2025 FY 10-K 2026-03-03 0001034842-26-000015
us-gaap RepaymentsOfLinesOfCredit Repayments of Lines of Credit USD 32.00M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001034842-26-000061
us-gaap RepaymentsOfLongTermCapitalLeaseObligations Repayments of Long-term Capital Lease Obligations USD 800,000 2011-01-01 2011-12-31 2013 FY 10-K 2014-03-04 0001047469-14-001756
us-gaap RepaymentsOfLongTermLinesOfCredit Repayments of Long-term Lines of Credit USD 55.25M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001034842-26-000061
us-gaap ResearchAndDevelopmentExpense Research and Development Expense USD 43.91M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001034842-26-000061
us-gaap ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost Research and Development Expense (Excluding Acquired in Process Cost) USD 22.61M 2025-01-01 2025-09-30 2025 Q3 10-Q 2025-11-04 0001104659-25-106268
us-gaap RestrictedCash Restricted Cash USD 57,000 2026-09-30 2026 Q3 10-Q 2026-11-05 0001034842-26-000061
us-gaap RestructuringAndRelatedCostNumberOfPositionsEliminated Restructuring and Related Cost, Number of Positions Eliminated employee 46 2016-09-01 2016-09-30 2018 FY 10-K 2019-02-28 0001558370-19-001310
us-gaap RestructuringAndRelatedCostNumberOfPositionsEliminatedPeriodPercent Restructuring and Related Cost, Number of Positions Eliminated, Period Percent pure 0.18 2013-09-01 2013-09-30 2015 FY 10-K 2016-03-08 0001558370-16-003898
us-gaap RestructuringCharges Restructuring Charges USD 1.32M 2022-01-01 2022-12-31 2024 FY 10-K 2025-03-04 0001558370-25-002169
us-gaap RestructuringCostsAndAssetImpairmentCharges Restructuring Costs and Asset Impairment Charges USD 100,000 2021-01-01 2021-12-31 2021 FY 10-K 2022-03-01 0001558370-22-002551
us-gaap RestructuringReserve Restructuring Reserve USD 64,000 2017-09-30 2017 Q3 10-Q 2017-11-07 0001558370-17-008378
us-gaap RetainedEarningsAccumulatedDeficit Retained Earnings (Accumulated Deficit) USD -983.91M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001034842-26-000061
us-gaap RevenueFromContractWithCustomerExcludingAssessedTax Revenue from Contract with Customer, Excluding Assessed Tax USD 218.41M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001034842-26-000061
us-gaap RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability Right-of-Use Asset Obtained in Exchange for Operating Lease Liability USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001034842-26-000061
us-gaap SalesRevenueNet Revenue, Net (Deprecated 2018-01-31) USD 6.65M 2018-01-01 2018-09-30 2018 Q3 10-Q 2018-11-06 0001558370-18-008624
us-gaap SellingGeneralAndAdministrativeExpense Selling, General and Administrative Expense USD 98.02M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001034842-26-000061
us-gaap SeveranceCosts1 Severance Costs USD 1.10M 2015-01-01 2016 Q1 10-Q 2016-05-03 0001558370-16-005199
us-gaap ShareBasedCompensation Share-based Payment Arrangement, Noncash Expense USD 15.15M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001034842-26-000061
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period shares 233,750 2021-01-01 2021-12-31 2021 FY 10-K 2022-03-01 0001558370-22-002551
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate pure 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-03 0001034842-26-000015
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized Share-based Compensation Arrangement by Share-based Payment Award, Number of Additional Shares Authorized shares 158,122 2024-07-01 2024-07-31 2024 Q3 10-Q 2024-11-07 0001558370-24-014862
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized shares 17.47M 2012-12-31 2012 FY 10-K 2013-03-05 0001047469-13-002185
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant shares 1.21M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001034842-26-000061
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost Share-based Payment Arrangement, Plan Modification, Incremental Cost USD 500,000 2023-01-01 2023-12-31 2023 FY 10-K 2024-03-05 0001558370-24-002475
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent Share-based Compensation Arrangement by Share-based Payment Award, Purchase Price of Common Stock, Percent pure 1 2012-01-01 2012-12-31 2012 FY 10-K 2013-03-05 0001047469-13-002185
us-gaap SharesPaidForTaxWithholdingForShareBasedCompensation Share-based Payment Arrangement, Shares Withheld for Tax Withholding Obligation shares 149,203 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001034842-26-000061
us-gaap ShortTermInvestments Short-term Investments USD 52.66M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001034842-26-000061
us-gaap StockholdersEquity Stockholders' Equity Attributable to Parent USD 445.11M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001034842-26-000061
us-gaap StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest USD 272.69M 2011-06-30 2011 Q2 10-Q 2011-08-02 0001104659-11-042450
us-gaap StockholdersEquityNoteStockSplitConversionRatio1 Stockholders' Equity Note, Stock Split, Conversion Ratio pure 0.1 2024-06-27 2025 FY 10-K 2026-03-03 0001034842-26-000015
us-gaap StockIssuedDuringPeriodSharesNewIssues Stock Issued During Period, Shares, New Issues shares 9.62M 2015-08-01 2016-12-31 2016 FY 10-K 2017-03-07 0001558370-17-001428
us-gaap StockIssuedDuringPeriodSharesStockOptionsExercised Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period shares 823,130 2018-01-01 2018-06-30 2018 Q2 10-Q 2018-08-08 0001558370-18-006758
us-gaap StockIssuedDuringPeriodValueNewIssues Stock Issued During Period, Value, New Issues USD 67.16M 2018-01-01 2018-12-31 2020 FY 10-K 2021-03-02 0001558370-21-002254
us-gaap StockIssuedDuringPeriodValueShareBasedCompensation Shares Issued, Value, Share-based Payment Arrangement, after Forfeiture USD 2.78M 2026-07-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001034842-26-000061
us-gaap SubleaseIncome Sublease Income USD 442,000 2023-01-01 2023-12-31 2024 FY 10-K 2025-03-04 0001558370-25-002169
us-gaap SupplementalUnemploymentBenefitsContinuationOfHealthCare Supplemental Unemployment Benefits, Continuation of Health Care USD 47,000 2014-12-31 2014 FY 10-K 2015-03-03 0001047469-15-001563
us-gaap SupplementalUnemploymentBenefitsSeveranceBenefits Supplemental Unemployment Benefits, Severance Benefits USD 187,000 2016-03-31 2016 Q1 10-Q 2016-05-03 0001558370-16-005199
us-gaap UnrecognizedTaxBenefits Unrecognized Tax Benefits USD 9.05M 2025-12-31 2025 FY 10-K 2026-03-03 0001034842-26-000015
us-gaap UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions Unrecognized Tax Benefits, Decrease Resulting from Prior Period Tax Positions USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-03 0001034842-26-000015
us-gaap UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued Unrecognized Tax Benefits, Income Tax Penalties and Interest Accrued USD 0 2025-12-31 2025 FY 10-K 2026-03-03 0001034842-26-000015
us-gaap UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions Unrecognized Tax Benefits, Increase Resulting from Current Period Tax Positions USD 270,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-03 0001034842-26-000015
us-gaap UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions Unrecognized Tax Benefits, Increase Resulting from Prior Period Tax Positions USD 11.33M 2015-01-01 2015-12-31 2016 FY 10-K 2017-03-07 0001558370-17-001428
us-gaap ValuationAllowanceDeferredTaxAssetChangeInAmount Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount USD -282.50M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-03 0001034842-26-000015
us-gaap ValuationAllowancesAndReservesAdjustments SEC Schedule, 12-09, Valuation Allowances and Reserves, Increase (Decrease) Adjustment USD -5.62M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001034842-26-000061
us-gaap ValuationAllowancesAndReservesBalance SEC Schedule, 12-09, Valuation Allowances and Reserves, Amount USD 26.81M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001034842-26-000061
us-gaap ValuationAllowancesAndReservesChargedToCostAndExpense SEC Schedule, 12-09, Valuation Allowances and Reserves, Additions, Charge to Cost and Expense USD 68.07M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001034842-26-000061
us-gaap ValuationAllowancesAndReservesDeductions SEC Schedule, 12-09, Valuation Allowances and Reserves, Deduction USD 63.35M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001034842-26-000061
us-gaap VariableLeaseCost Variable Lease, Cost USD 71,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-03 0001034842-26-000015
us-gaap VariableLeasePayment Variable Lease, Payment USD 600,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-03 0001034842-26-000015
us-gaap WeightedAverageNumberDilutedSharesOutstandingAdjustment Weighted Average Number Diluted Shares Outstanding Adjustment shares 1.34M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001034842-26-000061
us-gaap WeightedAverageNumberOfDilutedSharesOutstanding Weighted Average Number of Shares Outstanding, Diluted shares 19.90M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001034842-26-000061
us-gaap WeightedAverageNumberOfShareOutstandingBasicAndDiluted Weighted Average Number of Shares Outstanding, Basic and Diluted shares 170.30M 2021-01-01 2021-09-30 2021 Q3 10-Q 2021-11-02 0001558370-21-014076
us-gaap WeightedAverageNumberOfSharesOutstandingBasic Weighted Average Number of Shares Outstanding, Basic shares 18.56M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001034842-26-000061

Financialist News Desk

Our desk turns official SEC filings into news. Each story is checked against the original filing. About us → · Editorial standards →